Thermoenergy (TMENOB) 10-K 31 Mar 14 2013 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 24, 2014	Jun. 28, 2013
Document Information [Line Items]	'	'	'
Entity Registrant Name	'THERMOENERGY CORP	'	'
Entity Central Index Key	'0000884504	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Trading Symbol	'TMENOB	'	'
Entity Common Stock, Shares Outstanding	'	135,760,516	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Period Focus	'FY	'	'
Document Fiscal Year Focus	'2013	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Public Float	'	'	$2,974,761

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current Assets:	'	'
Cash and cash equivalents	$2,508	$4,657
Accounts receivable, trade	293	1,246
Accounts receivable, related party	229	0
Costs-in-excess of billings	317	597
Inventories, net	104	53
Deposits	31	1,566
Other current assets	178	146
Total Current Assets	3,660	8,265
Property and equipment, net	593	668
Other assets	40	0
TOTAL ASSETS	4,293	8,933
Current Liabilities:	'	'
Accounts payable	687	2,143
Short term borrowings	4,000	4,191
Convertible debt, net - current portion	2,083	1,250
Customer deposits	816	0
Billings-in-excess of costs	323	4,922
Derivative liabilities - current portion	0	20
Accrued payroll and other taxes	545	537
Accrued contract costs	59	1,545
Other current liabilities	476	851
Total Current Liabilities	8,989	15,459
Long Term Liabilities:	'	'
Derivative liabilities	186	2,214
Convertible debt, net	0	1,838
Other long term liabilities	15	33
Total Long Term Liabilities	201	4,085
Total Liabilities	9,190	19,544
Commitments and contingencies (Note 13)	'	'
Series C Convertible Redeemable Preferred Stock, $0.01 par value; liquidation preference of $1.52 per share: redeemable at $0.76 per share; designated: 15,000,000 shares at December 31, 2013; issued and outstanding: 13,853,106 shares at December 31, 2013	8,971	0
Stockholders' Deficiency:	'	'
Common Stock, $0.001 par value: authorized: 800,000,000 shares at December 31, 2013 and 425,000,000 at December 31, 2012; issued: 135,894,313 shares at December 31, 2013 and 120,588,372 shares at December 31, 2012; outstanding: 135,760,516 shares at December 31, 2013 and 120,454,575 shares at December 31, 2012	136	120
Additional paid-in capital	108,424	110,062
Accumulated deficit	-122,507	-120,892
Treasury stock, at cost: 133,797 shares at December 31, 2013 and 2012	-18	-18
Total Stockholders’ Deficiency for ThermoEnergy Corporation	-13,868	-10,609
Noncontrolling interest	0	-2
Total Stockholders' Deficiency	-13,868	-10,611
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	4,293	8,933
Series A Convertible Preferred Stock [Member]	'	'
Stockholders' Deficiency:	'	'
Preferred Stock value	2	2
Series B Convertible Preferred Stock [Member]	'	'
Stockholders' Deficiency:	'	'
Preferred Stock value	6	117
Series B-1 Convertible Preferred Stock [Member]	'	'
Stockholders' Deficiency:	'	'
Preferred Stock value	$89	$0

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS [Parenthetical] (USD $)	Dec. 31, 2013	Dec. 31, 2012
Preferred stock, par value (in dollars per share)	$0.01	$0.01
Preferred stock, shares authorized	50,000,000	30,000,000
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	800,000,000	425,000,000
Common stock, shares issued	135,894,313	120,588,372
Common stock, shares outstanding	135,760,516	120,454,575
Treasury stock, shares	133,797	133,797
Series A Convertible Preferred Stock [Member]	'	'
Preferred stock, liquidation value per share (in dollars per share)	$1.20	$1.20
Preferred stock, shares authorized	208,334	208,334
Preferred stock, shares issued	208,334	208,334
Preferred stock, shares outstanding	208,334	208,334
Series B Convertible Preferred Stock [Member]	'	'
Preferred stock, liquidation value per share (in dollars per share)	$2.40	$2.40
Preferred stock, shares authorized	1,000,000	12,000,000
Preferred stock, shares issued	551,725	11,664,993
Preferred stock, shares outstanding	551,725	11,664,993
Series C Convertible Preferred Stock [Member]	'	'
Preferred stock, par value (in dollars per share)	$0.01	'
Preferred stock, liquidation value per share (in dollars per share)	$1.52	'
Preferred stock, redemption price per share (in dollars per share)	$0.76	'
Preferred stock, shares authorized	15,000,000	'
Preferred stock, shares issued	13,853,106	'
Preferred stock, shares outstanding	13,853,106	'
Series B-1 Convertible Preferred Stock [Member]	'	'
Preferred stock, liquidation value per share (in dollars per share)	$2.40	$2.40
Preferred stock, shares authorized	11,000,000	11,000,000
Preferred stock, shares issued	8,919,854	0
Preferred stock, shares outstanding	8,919,854	0

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Revenue	$2,812	$6,971
Cost of revenue	3,313	6,798
Gross (loss) profit	-501	173
Operating Expenses:	'	'
General and administrative	3,179	4,751
Engineering, research and development	454	460
Sales and marketing	1,727	2,855
Total operating expenses	5,360	8,066
Loss from operations	-5,861	-7,893
Other income (expense):	'	'
Gain on contract termination	4,878	0
Derivative liability income	2,357	1,637
Other derivative expense	0	-567
Losses from equity method - joint ventures	-298	-8
Interest expense, net	-2,663	-529
Other expense	-28	-22
Total other income	4,246	511
Net loss	-1,615	-7,382
Net loss attributable to noncontrolling interest	0	4
Net loss attributable to ThermoEnergy Corporation	($1,615)	($7,378)
Loss per share attributable to ThermoEnergy Corporation, basic and diluted (in dollars per share)	($0.01)	($0.07)
Weighted average shares used in computing loss per share, basic and diluted (in shares)	131,776,778	103,184,422

CONSOLIDATED_STATEMENTS_OF_RED

CONSOLIDATED STATEMENTS OF REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIENCY) (USD $)	Total	Series C Redeemable Convertible Preferred Stock [Member]	Series A Convertible Preferred Stock [Member]	Series B Convertible Preferred Stock [Member]	Series B-1 Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Noncontrolling Interest [Member]
In Thousands, except Share data
Balance at Dec. 31, 2011	($4,603)	$0	$2	$117	$0	$85	$108,727	($113,510)	($18)	($6)
Balance (in shares) at Dec. 31, 2011	'	0	208,333	11,664,993	0	85,167,098	'	'	-133,797	'
Stock-based compensation expense	755	'	'	'	'	'	755	'	'	'
Common Stock issued for services	88	'	'	'	'	0	88	'	'	'
Common Stock issued for services (in shares)	'	'	'	'	'	419,180	'	'	'	'
Exercise of Common Stock warrants for cash, net of issuance costs of $38	498	'	'	'	'	6	492	'	'	'
Exercise of Common Stock warrants for cash, net of issuance costs of $38 (in shares)	'	'	'	'	'	5,633,344	'	'	'	'
Issuance of Common Stock for cash, net of issuance costs of $311	29	'	'	'	'	29	0	'	'	'
Issuance of Common Stock for cash, net of issuance costs of $311 (in shares)	'	'	'	'	'	29,368,750	'	'	'	'
Net Loss	-7,378	'	'	'	'	'	'	-7,382	'	4
Balance at Dec. 31, 2012	-10,611	0	2	117	0	120	110,062	-120,892	-18	-2
Balance (in shares) at Dec. 31, 2012	'	0	208,333	11,664,993	0	120,588,372	'	'	-133,797	'
Stock-based compensation expense	255	'	'	'	'	'	255	'	'	'
Recognition of beneficial conversion feature on short term borrowings	2,118	'	'	'	'	'	2,118	'	'	'
Conversion and tender of short term borrowings and accrued interest into Series C Convertible Redeemable Preferred Stock and warrants	778	4,485	'	'	'	'	778	'	'	'
Conversion and tender of short term borrowings and accrued interest into Series C Convertible Redeemable Preferred Stock and warrants (in shares)	'	6,926,553	'	'	'	'	'	'	'	'
Exchange of Series B Convertible Preferred Stock for Series C Convertible Redeemable Preferred Stock	-4,486	4,486	'	-22	'	'	-4,464	'	'	'
Exchange of Series B Convertible Preferred Stock for Series C Convertible Redeemable Preferred Stock (in shares)	'	6,926,553	'	-2,193,414	'	'	'	'	'	'
Exchange of Series B Convertible Preferred Stock for Series B-1 Convertible Preferred Stock	0	'	'	-89	89	'	'	'	'	'
Exchange of Series B Convertible Preferred Stock for Series B-1 Convertible Preferred Stock (in shares)	'	'	'	-8,919,854	8,919,854	'	'	'	'	'
Recognition of derivative liabilities	-607	'	'	'	'	'	-607	'	'	'
Cashless exercise of Common Stock warrants	288	'	'	'	'	6	282	'	'	'
Cashless exercise of Common Stock warrants (in shares)	'	'	'	'	'	6,031,577	'	'	'	'
Issuance of Common Stock to settle anti-dilution obligations	10	'	'	'	'	10	'	'	'	'
Issuance of Common Stock to settle anti-dilution obligations (in shares)	'	'	'	'	'	9,274,364	'	'	'	'
Repayment of noncontrolling interest in joint venture	2	'	'	'	'	'	'	'	'	2
Net Loss	-1,615	'	'	'	'	'	'	-1,615	'	'
Balance at Dec. 31, 2013	($13,868)	$8,971	$2	$6	$89	$136	$108,424	($122,507)	($18)	$0
Balance (in shares) at Dec. 31, 2013	'	13,853,106	208,333	551,725	8,919,854	135,894,313	'	'	-133,797	'

CONSOLIDATED_STATEMENTS_OF_RED1

CONSOLIDATED STATEMENTS OF REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIENCY) [Parenthetical] (USD $)	12 Months Ended
	Dec. 31, 2012
Issuance Cost Of Common Stock Purchase Warrants	$38
Issuance Cost Of Common Stock For Cash	$311

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Operating Activities:	'	'
Net loss	($1,615)	($7,382)
Adjustment to reconcile net loss to net cash used in operating activities:	'	'
Stock-based compensation	255	755
Common stock issued for services	0	88
Gain on contract termination	-4,878	0
Loss on disposal of equipment	0	131
Equity in losses of joint ventures	298	8
Derivative liability income	-2,357	-1,637
Other derivative expense	0	567
Non-cash interest added to note receivable	-7	0
Non-cash interest added to debt	121	90
Depreciation	189	119
Amortization of discount on convertible debt	2,202	154
Changes in operating assets and liabilities:	'	'
Accounts receivable, trade	953	2,982
Accounts receivable, related party	-429	0
Costs-in-excess of billings	280	-465
Inventories	-51	-125
Deposits	1,535	-1,304
Other current assets	-61	350
Accounts payable	-1,456	-497
Customer deposits	816	0
Billings-in-excess of costs	279	-209
Accrued payroll and other taxes	8	-204
Accrued contract costs	-1,486	1,526
Other current liabilities	49	-299
Other long term liabilities	-18	-27
Net cash used in operating activities	-5,373	-5,379
Investing Activities:	'	'
Investment in joint ventures	0	-100
Issuance of note receivable to affiliate	-100	-100
Purchases of property and equipment	-114	-135
Net cash used in investing activities	-214	-335
Financing Activities:	'	'
Proceeds from issuance of common stock, net of issuance costs of $349 in 2012	0	3,124
Proceeds from issuance of short term borrowings	4,223	4,191
Repayment of short term borrowings	-785	0
Net cash provided by financing activities	3,438	7,315
Net change in cash and cash equivalents	-2,149	1,601
Cash and cash equivalents, beginning of year	4,657	3,056
Cash and cash equivalents, end of year	2,508	4,657
Supplemental schedule of non-cash financing activities:	'	'
Accrued interest added to debt	40	23
Recognition of derivative liabilities	607	3,064
Debt discount recognized on convertible debt	2,117	0
Conversion of convertible debt and accrued interest to Series C Redeemable Convertible Preferred Stock	5,264	0
Exchange of Series B Convertible Preferred Stock to Series C Redeemable Convertible Preferred Stock	4,486	0
Exchange of Series B Convertible Preferred Stock to Series B-1 Convertible Preferred Stock	89	0
Cashless exercise of warrants for Common Stock	288	0
Anti-dilutive issuance of Common Stock to investors	10	0
Transfer of accounts receivable - related party to notes receivable	200	0
Tender of Roenigk 2007 and 2008 Convertible Promissory Notes in exchange for Roenigk 2012 Convertible Promissory Note	$0	$1,877

CONSOLIDATED_STATEMENTS_OF_CAS1

CONSOLIDATED STATEMENTS OF CASH FLOWS [Parenthetical] (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012
Common Stock Issuance Cost	$349

Organization_and_summary_of_si

Organization and summary of significant accounting policies	12 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	'
	Note 1:   Organization and summary of significant accounting policies
	Nature of business
	ThermoEnergy Corporation (“the Company”) was incorporated in January 1988 for the purpose of developing and marketing advanced municipal and industrial wastewater treatment and carbon reducing power generation technologies.
	The Company’s wastewater treatment systems are based on its proprietary Controlled Atmosphere Separation Technology (“CAST®”) platform.  The Company’s patented and proprietary platform technology is combined with off-the-shelf technologies to provide systems that are inexpensive, easy to operate and reliable. The Company’s wastewater treatment systems have global applications in metal finishing, heavy manufacturing, hydraulic fracturing, petrochemical, refining, aerospace, food and beverage processing, pulp and paper, microchip and circuit board manufacturing and municipal wastewater. The CAST® platform technology is owned by its subsidiary, CASTion Corporation (“CASTion”).
	The Company also owns a patented pressurized oxycombustion technology that converts fossil fuels (including coal, oil and natural gas) and biomass into electricity while producing near zero air emissions and removing and capturing carbon dioxide in liquid form for sequestration or beneficial reuse. This technology is intended to be used to build new or to retrofit old fossil fuel power plants globally with near zero air emissions while capturing carbon dioxide as a liquid for ready sequestration far more economically than any other competing technology. The pressurized oxycombustion  technology is held in the Company’s subsidiary, ThermoEnergy Power Systems, LLC (“TEPS”).
	The Company’s pressurized oxycombustion technology and the water technologies are collectively referred to as the “Technologies.”
	Principles of consolidation and basis of presentation
	The consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Financial results for Unity Power Alliance (“UPA”) have been consolidated for the period from inception until the date it became a Joint Venture on July 16, 2012. Financial results for UPA as a Joint Venture are accounted for under the equity method of accounting for investments, as discussed in Note 4.
	Certain prior year amounts have been reclassified to conform to current year classifications. The Company separated the balance of accrued payroll and other taxes from other current liabilities; these amounts were included as part of other current liabilities on the Company’s Consolidated Balance Sheet as of December 31, 2012. Additionally, the Company reduced its balance of notes receivable, with an offsetting reduction of long term liabilities, by $100,000 compared to amounts reports on the Company’s Consolidated Balance Sheet as of December 31, 2012 to consistently report activity related to its investments in UPA.
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates affecting amounts reported in the consolidated financial statements relate to revenue recognition, recognition of derivative liabilities and accruals for payroll and other taxes.
	The 15% third party ownership interest in TEPS is recorded as a noncontrolling interest in the consolidated financial statements.
	Revenue recognition
	Historically, the Company has recognized revenues using the percentage-of-completion method. Under this approach, revenue is earned in proportion to total costs incurred in relation to total costs expected to be incurred. Project costs include all direct material and labor costs and indirect costs related to project performance, such as indirect labor, supplies, tools, repairs and depreciation.
	Recognition of revenue and profit under the percentage-of-completion method is dependent upon a number of factors, including the accuracy of a variety of estimates made at the balance sheet date such as engineering progress, materials quantities, as well as achievement of milestones, penalty provisions, labor productivity and cost estimates made. Due to uncertainties inherent in the estimation process, actual completion costs may vary from estimates. Changes in job performance, job conditions and estimated profitability may result in revisions to costs and income and are recognized beginning in the period in which they become known. Provisions for estimated losses on uncompleted contracts are made in the period in which the estimated loss first becomes known.
	Certain long-term projects include a number of different services to be provided to the customer. The Company records separately revenues, costs and gross profit related to each of these services if they meet the contract segmenting criteria.
	In circumstances when the Company cannot estimate the final outcome of a project, or when the Company cannot reasonably estimate revenue, the Company utilizes the percentage-of-completion method based on a zero profit margin until more precise estimates can be made. If and when the Company can make more precise estimates, revenues are adjusted accordingly and recorded as a change in an accounting estimate. The Company recorded revenue from one project which represented 21% and less than 1% of its revenues for the years ended December 31, 2013 and 2012, respectively, utilizing the percentage of completion method based on a zero profit margin.
	Effective October 1, 2013, the Company launched changes to its operations to emphasize standardized systems and manufacturing processes and has commenced selling wastewater treatment systems based on these changes. The Company recognizes revenue on the sale of its wastewater treatment systems from this new standardized process at the point of shipment or transfer of title, provided there is persuasive evidence of an arrangement, the fee is fixed and determinable, and the collectability of the related receivable is probable. Amounts received from customers in advance of shipment are recorded within customer deposits.
	The Company recognizes revenues on its contract with UPA on a time-and-materials basis.
	Revenue from spare parts sales is recognized upon shipment or title transfer under the terms of the customer contract.
	Service revenue is recognized upon the completion and acceptance of the work performed.
	Variable interest entities
	The Company assesses whether its involvement with another related entity constitutes a variable interest entity (“VIE”) through either direct or indirect variable interest in that entity. If an entity is deemed to be a VIE, the Company must determine if it is the primary beneficiary (i.e. the party that consolidates the VIE), in accordance with the accounting standard for the consolidation of variable interest entities. The Company qualitatively evaluates if it is the primary beneficiary of the VIE’s based on whether the Company has (i) the power to direct those matters that most significantly impacted the activities of the VIE; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE. See Note 4 for further discussion of UPA as a variable interest entity.
	Cash and cash equivalents
	The Company places its cash in highly rated financial institutions, which are continually reviewed by senior management for financial stability. Generally the Company’s cash in interest-bearing accounts exceeds financial depository insurance limits. However, the Company has not experienced any losses in such accounts and believes that its cash is not exposed to significant credit risk.
	The Company has a cash management program which provides for the investment of excess cash balances primarily in money market funds, which are valued using Level 1 inputs. The Company considers such highly liquid investments with original maturities of three months or less when purchased to be cash equivalents.
	Accounts receivable, net
	Accounts receivable are recorded at their estimated net realizable value. Receivables related to the Company’s contracts have realization and liquidation periods of less than one year and are therefore classified as current.
	The Company maintains allowances for specific doubtful accounts based on estimates of losses resulting from the inability of customers to make required payments and record these allowances as a charge to general and administrative expense. The Company’s method for estimating its allowance for doubtful accounts is based on judgmental factors, including known and inherent risks in the underlying balances, adverse situations that may affect the customer’s ability to pay and current economic conditions. Amounts considered uncollectible are written off based on the specific customer balance outstanding.
	The following is a summary of the Company’s allowance for doubtful accounts activity for the year ended December 31, 2013: (in thousands)
	Allowance for doubtful accounts, beginning of year		$	—
	Bad debt expense			5
	Write-offs			-5
	Allowance for doubtful accounts, end of year		$	—
	The Company did not have any activity in its allowance for doubtful accounts for the year ended December 31, 2012.
	At December 31, 2013, two customers accounted for 81% of the Company’s total accounts receivable balance. At December 31, 2012, one customer accounted for 53% of the Company’s accounts receivable balance. For the year ended December 31, 2013, three customers each accounted for more than 10% of the Company’s revenues and collectively accounted for 76% of total revenues. For the year ended December 31, 2012, one customer accounted for 73% of the Company’s revenues.
	Inventories, net
	Inventories are stated at the lower of cost or net realizable value using the first-in, first-out method and are comprised of the following as of December 31, 2013 and 2012: (in thousands)
			2013			2012
	Raw materials		$	192		$	187
	Work in process			46			—
				238		$	187
	Less: Reserve for excess and obsolete inventory			-134			-134
			$	104		$	53
	The Company evaluates its inventory for excess quantities and obsolescence on a periodic basis.  In preparing its evaluation, the Company looks at the expected demand for its products for the next three to twelve months.  Based on this evaluation, the Company records provisions to ensure that inventory is appropriately stated at the lower of cost or net realizable value.
	Property and equipment
	Property and equipment are stated at cost and are depreciated over the estimated useful life of each asset. Depreciation is computed using the straight-line method.  Property and equipment are comprised of the following as of December 31, 2013 and 2012: (in thousands)
			Estimated Useful Lives		2013			2012
	Computers and software		3-5 years		$	254		$	198
	Furniture and fixtures		7 years			50			50
	Demonstration equipment		7 years			464			604
	Leasehold improvements		life of lease			168			110
	Production and laboratory equipment		7 years			126			126
						1,062		$	1,088
	Less: Accumulated depreciation					-469			-420
					$	593		$	668
	Depreciation expense was $189,000 and $119,000 for the years ended December 31, 2013 and 2012, respectively.
	The Company evaluates long-lived assets based on estimated future undiscounted net cash flows or other fair value measures whenever significant events or changes in circumstances occur that indicate the carrying amount may not be recoverable. If that evaluation indicates that an impairment has occurred, a charge is recognized to the extent the carrying amount exceeds the undiscounted cash flows or fair values of the asset, whichever is more readily determinable.
	The Company recorded a loss of $131,000 in 2012 related to the disposal of a system previously used for pre-sales testing. This loss is included in sales and marketing expense on its Consolidated Statement of Operations for the year ended December 31, 2012.
	Taxes to governmental authorities
	The Company collects sales taxes but excludes such amounts from revenues.
	Shipping and handling costs
	Shipping and handling costs that are billed to customers are included in cost of goods sold in the accompanying statements of operations.
	Advertising costs
The Company expenses advertising costs as incurred. During the years ended December 31, 2013 and 2012, the Company incurred advertising expense in the amounts of $27,000 and $37,000, respectively.
Contingencies
The Company accrues for costs relating to litigation, including litigation defense costs, claims and other contingent matters, including liquidated damage liabilities, when such liabilities become probable and reasonably estimable. Such estimates may be based on advice from third parties or on management’s judgment, as appropriate. Revisions to payroll tax and other accruals are reflected in income in the period in which different facts or information become known or circumstances change that affect the Company’s previous assumptions with respect to the likelihood or amount of loss. Amounts paid upon the ultimate resolution of contingent liabilities may be materially different from previous estimates and could require adjustments to the estimated liability to be recognized in the period such new information becomes known.
Stock options
The Company accounts for stock options in accordance with Accounting Standards Codification (“ASC”) Topic 718, “Compensation – Stock Compensation.” This topic requires that the cost of all share-based payments to employees, including grants of employee stock options, be recognized in the financial statements based on their fair values on the measurement date, which is generally the date of grant.  Such cost is recognized over the vesting period of the awards.  The Company uses the Black-Scholes option pricing model to estimate the fair value of “plain vanilla” stock option awards.
Income taxes
The Company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax basis of assets and liabilities and are measured using enacted rates and laws that will be in effect when the deferred tax assets or liabilities are expected to be realized or settled. A valuation allowance for deferred tax assets is provided if it is more likely than not that all or a portion of the deferred tax assets will not be realized. The Company recognizes interest and penalties related to underpayments of income taxes as a component of interest and other expense on its Consolidated Statement of Operations.
The Company estimates contingent income tax liabilities based on the guidance for accounting for uncertain tax positions as prescribed in ASC Topic 740, “Income Taxes.” The Company uses a two-step process to assess each income tax position.  It first determines whether it is more likely than not that the income tax position will be sustained, based on technical merits, upon examination by the taxing authorities.  If the income tax position is expected to meet the more likely than not criteria, the Company then records the benefit in the financial statements that equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement.  At December 31, 2013 and 2012, there are no uncertain tax positions that require accrual.
The Company is subject to taxation in the U.S. and various states. As of December 31, 2013 the Company’s tax years for 2010, 2011, 2012 and 2013 are subject to examination by the tax authorities. As of December 31, 2013, the Company is no longer subject to U.S. federal, state or local examinations by tax authorities for years before 2010. Tax year 2009 was open as of December 31, 2012.
Fair value of financial instruments and fair value measurements
The carrying amount of cash and cash equivalents, accounts receivable, other current assets, accounts payable, short term borrowings and other current liabilities in the consolidated financial statements approximate fair value because of the short-term nature of those instruments. The carrying amount of the Company’s convertible debt and short term borrowings was $6,083,000 and $7,279,000 at December 31, 2013 and 2012, respectively, and approximates its fair value, as the interest rate on this debt approximates the interest rate of the Company’s recent borrowings. The Company’s derivative liabilities are recorded at fair value. See Note 8 for further information on derivative liabilities.
The Company's assets and liabilities carried at fair value are categorized using inputs from the three levels of fair value hierarchy, as follows:
	Level 1:	Quoted prices in active markets for identical assets or liabilities.
	Level 2:	Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3:	Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the liabilities.
Earnings (loss) per share
Basic earnings (loss) per share (“EPS”) is computed by dividing the net income (loss) attributable to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator) during the reporting periods. Fully diluted earnings per share is computed by increasing the denominator by the weighted average number of additional shares that could have been outstanding from securities convertible into common stock, such as stock options and warrants (using the “treasury stock” method), and convertible preferred stock and debt (using the “if-converted” method), unless the effect on net income per share is antidilutive. Under the “if-converted” method, convertible instruments are assumed to have been converted as of the beginning of the period or when issued, if later. The computations of diluted net loss per share do not include 0 and 392,326 options and warrants which were outstanding as of the years ended December 31, 2013 and 2012, respectively, as the inclusion of these securities would have been anti-dilutive.
Concentration of Credit Risk
Financial instruments which potentially expose the Company to concentrations of credit risk include cash equivalents, trade accounts receivable, accounts payable and accrued liabilities. The Company restricts its cash equivalents to money market accounts with major banks and U.S. government and corporate securities which are subject to minimal credit and market risk.
Recent accounting pronouncements
In July 2013, the FASB issued ASU 2013-11, Presentation of Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists, an amendment to FASB Accounting Standards Codification (“ASC”) Topic 740, Income Taxes (“FASB ASC Topic 740”). This update clarifies that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. In situations where a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction or the tax law of the jurisdiction does not require, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013. The adoption of this ASU is not expected to have a material impact on the Company’s financial statements.
There were no other accounting standards recently issued that had or are expected to have a material impact on the Company’s consolidated financial statements and associated disclosures.

Managements_consideration_of_g

Management's consideration of going concern matters	12 Months Ended
	Dec. 31, 2013
Managements Consideration Of Going Concern Matters [Abstract]	'
Managements Consideration of Going Concern Matters [Text Block]	'
	Note 2: Management's consideration of going concern matters
	The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has sustained substantial losses from operations in recent years, and such losses have continued through the year ended December 31, 2013.
	At December 31, 2013, the Company had cash of approximately $2.5 million. The Company has incurred net losses since inception, including a net loss of approximately $1.6 million during the year ended December 31, 2013 and had an accumulated deficit of approximately $122.5 million at December 31, 2013.
	In view of the matters described in the preceding paragraph, recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon continued operations of the Company, which in turn is dependent upon the Company’s ability to meet its financing requirements on a continuing basis, to maintain present financing, and to succeed in its future operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.
	These uncertainties raise substantial doubt about the Company's ability to continue as a going concern. The financial statements included in this Form 10-K have been prepared on a going concern basis and as such do not include any adjustments that might result from the outcome of this uncertainty.
	Management is actively building and developing its sales pipeline to generate future revenues. Management and an independent committee of the Company’s Board of Directors are also evaluating alternatives for funding to continue operations under the Company’s existing structure.
	As more fully described in Notes 6, 7 and 8, on April 5, 2013, the Company issued shares of Series C Convertible Redeemable Preferred Stock in exchange for the entire principal and accrued interest amounts of the Company’s December 2011 Bridge Notes and the Company’s November 2012 Bridge Notes. Additionally, as more fully described in Note 5, on August 22, 2013, the Company received proceeds totaling $4,000,000 from the issuance of 12% Promissory Notes.

NYCDEP_Contract

NYCDEP Contract	12 Months Ended
	Dec. 31, 2013
Risks and Uncertainties [Abstract]	'
Concentration Risk Disclosure [Text Block]	'
	Note 3: NYCDEP Contract
	On August 22, 2012, the City of New York Department of Environmental Protection (the “NYCDEP”) issued a stop work order to the Company relative to its contract to install an Ammonia Removal Process (“ARP”) system at the NYCDEP’s wastewater treatment facility in the 26th Ward. On November 13, 2012, the NYCDEP notified the Company that it is terminating the contract, effective November 29, 2012.
	The Company suspended all work on this contract as of August 22, 2012 and suspended all work with its major vendors. Upon notification of the contract termination, the Company cancelled all orders from its major vendors. The Company ceased recognition of revenues as of November 29, 2012 with the exception of processing one change order in the first quarter of 2013, and the Company recorded all incremental costs as period costs on its Consolidated Statement of Operations.
	The Company received all amounts billed to the NYCDEP related to this contract, and the Company delivered all equipment, including all material from third party vendors, to the NYCDEP during the first quarter of 2013. In June 2013, the Company received notice from the NYCDEP that the contract had been closed. Accordingly, the Company recorded a gain on contract termination of approximately $4.9 million in the second quarter of 2013, which represents the amount the Company billed in accordance with the contract in excess of revenues recognized.

Joint_Ventures

Joint Ventures	12 Months Ended
	Dec. 31, 2013
Joint Venture [Abstract]	'
Joint Venture [Text Block]	'
	Note 4:  Joint Ventures
	Babcock-Thermo Clean Combustion LLC
	On February 25, 2009, the Company’s subsidiary, TEPS, and  Babcock Power Development, LLC (“BPD”), a subsidiary of Babcock Power, Inc., entered into a Limited Liability Company Agreement (the “LLC Agreement”) establishing Babcock-Thermo Carbon Capture LLC, a Delaware limited liability company (the “Joint Venture”) for the purpose of developing its proprietary pressurized oxycombustion technology.  In 2011, the joint venture changed its name to Babcock-Thermo Clean Combustion LLC.
	Pursuant to the LLC Agreement, each of ThermoEnergy Power Systems and BPD owned a 50% membership interest in the Joint Venture.  The LLC Agreement provides that each member may be required, from time to time, to make capital contributions to the Joint Venture to fund its operations.
	The Company accounted for the Joint Venture using the equity method of accounting. Accordingly, the Company reduced the value of its investment in the Joint Venture by $2,000 in 2013 and $26,000 in 2012 to account for its share of net losses incurred by the Joint Venture. The carrying value of the Company’s investment in the Joint Venture is $10,000 as of December 31, 2012, and is classified as Other Assets on the Company’s Consolidated Balance Sheets.
	On March 2, 2012, TEPS entered into a Dissolution Agreement with BPD to terminate the Limited Liability Company Agreement and dissolve the Joint Venture, and the Joint Venture was dissolved on April 30, 2013.
	Unity Power Alliance LLC
	On March 8, 2012, the Company announced the formation of Unity Power Alliance LLC (“UPA”). UPA was formed with the intention to work with partners and stakeholders to develop and commercialize its pressurized oxycombustion technology.
	On June 20, 2012, the Company entered into an agreement with Itea S.p.A. (“Itea”) for the development of pressurized oxycombustion in North America. The two parties, through UPA, will utilize the two parties’ propriety technology to advance, develop and promote the use of the coal application of pressurized oxycombustion, construct a pilot plant utilizing the technology, and subsequently construct a demonstration facility based on the technology as implemented in the pilot plant. Itea was granted the option to acquire a 50% ownership interest in UPA for $1,250. On July 16, 2012, Itea exercised its option and acquired the 50% ownership interest in UPA.
	UPA is governed by a Board of Directors, with half of the directors nominated by each of the Company and Itea. Administrative expenses of UPA are borne jointly by the Company and Itea, and financing for development expenses will be obtained from third parties and the members of the joint venture.
	Also on June 20, 2012 the Company and Itea entered into a License Agreement whereby the Company and the Company’s majority-owned subsidiary, TEPS, and Itea granted a non-exclusive, non-transferable royalty-free license to UPA to use their intellectual property relating to pressurized oxycombustion. The licenses to UPA became effective upon Itea’s acquisition of its ownership interest in UPA. The License Agreement further provides that, if UPA successfully obtains funding and project support to construct the pilot plant, the parties may grant licenses of their respective intellectual property and know-how to each other or to third parties for the operation of power plants based on such intellectual property and know-how, and royalties will be shared as defined in the License Agreement.
	In September 2012, UPA was awarded a $1 million Phase 1 grant from the U.S. Department of Energy to help fund a project under a special DOE program to advance technologies for efficient, clean coal power and carbon capture. As part of UPA's project, in October 2012, the Company received a $900,000 subcontract order from UPA to build a bench-scale “flameless” combustion reactor under the grant using Itea’s design. As a subcontractor for this project, the Company was required by the DOE to provide a guarantee that the project would be completed in its entirety. UPA and its subcontractors received contract definitization during the first quarter of 2013 and began to receive funding. As of December 31, 2013, UPA has received funding totaling $901,000 related to this grant from the DOE. The Company, as a subcontractor to UPA, has recorded revenues of $842,000, as well as related expenses totaling $896,000, associated with this contract during the year ended December 31, 2013, and the Company has accounts receivable related to this contract of approximately $293,000 as of December 31, 2013.
	In October 2012, the Company and Itea entered into a Loan Agreement with UPA through which funds required to maintain the operations of the joint venture would be loaned in the form of notes receivable. The notes bear interest at the three-month LIBOR rate plus 2% per year, with interest calculated monthly and added to the balance of the notes. The Company loaned $100,000 and converted accounts receivable of $200,000 into a loan under this Loan Agreement; Itea loaned $300,000 to UPA in 2013. Each party loaned $100,000 in 2012 in conjunction with this Loan Agreement. Investments and loans made by the Company to UPA are being utilized to fund UPA’s share of the costs to complete the project and operating expenses of UPA.
	In accordance with ASC 810, Consolidation, the Company determined that it held a variable interest in UPA and that UPA was a variable-interest entity. However, the Company has concluded that it is not required to consolidate the financial statements of UPA for the years ended December 31, 2013 and 2012. The Company reviewed the most significant activities of UPA and determined that because the Company shares the power to direct the activities of UPA with Itea, it is not the primary beneficiary of UPA. Accordingly, the financial results of UPA are accounted for under the equity method of accounting for investments.
	Financial results for UPA have been consolidated for the period from inception until July 16, 2012, when Itea acquired its 50% ownership interest in UPA. Accordingly, the Company included $129,000 of sales and marketing expense related to UPA on its Consolidated Statement of Operations for the year ended December 31, 2012. The Company accounted for UPA using the equity method of accounting after Itea acquired its ownership interest. The Company decreased the value of its investment in the Joint Venture by $296,000 in 2013 and increased the value of its investment by $18,000 in 2012 to account for its share of net income and losses. The carrying value of the Company’s investment in the Joint Venture is $0 as of December 31, 2013 and 2012, as the Company’s share of losses incurred by UPA exceeds the Company’s investments.
	The following is a summary of the assets, liabilities and results of operations for UPA for the year ended December 31, 2013 and 2012 (in thousands):
		2013		2012
	Current assets	$	87	$	77
	Non-current assets		4		7
	Current liabilities		1,111		305
	Non-current liabilities		0		0
	Revenue		901		0
	Operating expenses		1,687		222
	Net loss		799		223

Short_term_borrowings

Short term borrowings	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Short-term Debt [Text Block]	'
	Note 5: Short term borrowings
	Short term borrowings consisted of the following at December 31, 2013 and 2012 (in thousands):
		2013		2012
	Project Financing Line of Credit	$	—	$	491
	November 2012 Bridge Notes, 8%, due April 15, 2013		—		3,700
	August 2013 Bridge Notes, 12%, due February 1, 2014		4,000		—
		$	4,000	$	4,191
	Project Financing Line of Credit
	On October 4, 2012, the Company entered into a Loan Agreement (the “Loan Agreement”) with C13 Thermo LLC (the “Lender”), a related party whose owners are related to an officer of the Company. Under this Loan Agreement, the Lender established a credit facility allowing the Company to borrow up to $700,000 (the “Credit Facility”) to finance the fabrication and testing of an Ammonia Reduction Process system utilizing the Company’s proprietary technology (the “Project”). The Company issued to the Lender a promissory note in the principal amount of $700,000 (the “Note”). The Company borrowed approximately $680,000 against this Credit Facility, and the Company agreed to reimburse legal fees of $34,000 to the Lender in 2013. As of December 31, 2012 the Company borrowed approximately $491,000 against this Credit Facility.
	Amounts borrowed under the Credit Facility did not bear interest (except in the case of an event of default, in which case all amounts borrowed, together with all fees, expenses and other amounts due, would bear interest at the default rate of 8% per annum). Upon maturity of the Note, the Company was charged a commitment fee equal to 10% of the aggregate principal amount borrowed under the Credit Facility. The Credit Facility expired, and all amounts due under the Note, together with all commitment fees incurred under the Loan Agreement, became due and payable, on the earlier of (i) March 4, 2013 or (ii) the date on which the Company first drew against an irrevocable documentary letter of credit that was issued for the Company’s benefit in connection with the Project. The Credit Facility was amended in March 2013 to extend the expiration date to the earlier of (i) April 5, 2013 or (ii) one business day following the date the Company first drew against the irrevocable documentary letter of credit. The Company could repay the Note in whole or in part at any time without premium or penalty. The Credit Facility was secured by all of the Company’s assets.
	On April 5, 2013 the Company repaid in full all outstanding principal, legal fees and accrued commitment fees totaling $785,000 related to this Credit Facility.
	November 2012 Bridge Note Financing
	On November 30, 2012 the Company entered into Bridge Loan Agreements with six of its principal investors pursuant to which the investors agreed to make bridge loans to the Company of $3.7 million in exchange for 8% Promissory Notes (the “November 2012 Bridge Notes”).  The November 2012 Bridge Notes bore interest at the rate of 8% per year and were due and payable on April 15, 2013.
	The November 2012 Bridge Notes contained other conventional terms, including representations and warranties regarding the Company’s business and assets and its authority to enter into such agreements, and provisions for acceleration of the Company’s obligations upon the occurrence of certain specified events of default.
	On April 5, 2013 the investors converted the outstanding principal of the November 2012 Bridge Notes, plus accrued interest, into 5,005,250 shares of the Company’s Series C Convertible Redeemable Preferred Stock and Warrants for the purchase of 50,052,500 shares of the Company’s Common Stock.
	August 2013 Bridge Note Financing
	On August 22, 2013 the Company entered into Bridge Loan Agreements with four of its principal investors pursuant to which the investors agreed to make bridge loans to the Company of $4 million in exchange for 12% Promissory Notes (the “August 2013 Bridge Notes”). The August 2013 Bridge Notes bear interest at the rate of 12% per year and are due and payable on February 1, 2014. The August 2013 Bridge Notes are secured by substantially all of the Company’s assets.
	The August 2013 Bridge Notes contain other conventional terms, including representations and warranties regarding the Company’s business and assets and its authority to enter into such agreements, and provisions for acceleration of the Company’s obligations upon the occurrence of certain specified events of default.
	As further detailed in Note 14, on February 28, 2014 the Company entered into a Standstill Agreement with the holders of the August 2013 Bridge Notes and the Roenigk 2012 Convertible Promissory Note (see Note 6), where the holders of these notes agreed not to commence enforcement, collection or similar proceedings with respect to these notes until May 1, 2014.

Convertible_debt

Convertible debt	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	Note 6: Convertible debt
	Convertible debt consisted of the following at December 31, 2013 and 2012 (in thousands):
		2013		2012
	December 2011 Convertible Promissory Notes, 12.5%, due on demand on or after January 31, 2013	$	—	$	1,250
	Roenigk 2012 Convertible Promissory Note, 8%, due March 31, 2014, less discount of $22 at December 31, 2013 and $106 at December 31, 2012		2,083		1,838
			2,083		3,088
	Less: Current portion		-2,083		-1,250
		$	—	$	1,838
	March 21, 2007 Financing
	On March 21, 2007 the Company issued to Mr. Martin A. Roenigk, a member of the Company’s Board of Directors as of that date, a 5% Convertible Promissory Note due March 21, 2013 in the principal amount of $750,000. The principal amount and accrued interest on the Note was convertible into shares of common stock at a conversion price of $0.50 per share at any time at the election of the holder.  As further consideration, the Company issued a warrant to purchase 750,000 shares of common stock at an exercise price equal to the daily volume weighted average price per share of the common stock for the 365-day period immediately preceding the date on which the warrant is exercised, subject to a minimum exercise price of $0.50 per share and a maximum exercise price of $1.00 per share. The warrant expired on March 21, 2013.
	Interest on the Note was payable semi-annually. The Company could, at its discretion, defer any scheduled interest payment until the maturity date of the Note upon payment of a $2,500 deferral fee.  The Company added $213,000 of accrued interest to the principal balance of the Note as of June 20, 2012.
	On June 20, 2012, the Noteholder tendered this Note, together with the 2008 Convertible Promissory Note discussed below, as consideration for the issuance of the 2012 Convertible Promissory Note, as discussed below.
	March 7, 2008 Financing
	On March 7, 2008, Mr. Roenigk exercised his option to make an additional $750,000 investment in the Company under the terms of the Securities Purchase Agreement between the Company and Mr. Roenigk dated March 21, 2007. The Company issued to Mr. Roenigk a 5% Convertible Promissory Note due March 7, 2013 in the principal amount of $750,000. The principal amount and accrued interest on the Note was convertible into shares of common stock at a conversion price of $0.50 per share at any time at the election of the holder. As further consideration, the Company issued a warrant to purchase 750,000 shares of common stock at an exercise price equal to the daily volume weighted average price per share of the Company’s common stock for the 365-day period immediately preceding the date on which the warrant is exercised, subject to a minimum exercise price of $0.50 per share and a maximum exercise price of $1.00 per share. The warrant expires on March 7, 2014.
	Interest on the Note was payable semi-annually. The Company could, at its discretion, defer any scheduled interest payment until the maturity date of the Note upon payment of a $2,500 deferral fee.  The Company added $165,000 of accrued interest to the principal balance of the Note as of June 20, 2012.
	On June 20, 2012, the Noteholder tendered this Note, together with the 2007 Convertible Promissory Note discussed above, as consideration for the issuance of the 2012 Convertible Promissory Note, as discussed below.
	December 2011 Bridge Note Financing
	On December 2, 2011 the Company entered into Bridge Loan Agreements with four of its principal investors pursuant to which the investors agreed to make bridge loans to the Company of $1.25 million in exchange for 12.5% Promissory Notes (the “December 2011 Bridge Notes”).  The December 2011 Bridge Notes bore interest at the rate of 12.5% per year and were due and payable on December 31, 2012. The entire unpaid principal amount, together with all interest then accrued and unpaid under each December 2011 Bridge Note, was convertible into shares of a future series of Preferred Stock.
	The December 2011 Bridge Notes contained other conventional provisions, including the acceleration of repayment obligations upon the occurrence of certain specified Events of Default.
	On November 30, 2012, in conjunction with the issuance of the November 2012 Bridge Notes (see Note 5), the investors who participated in the December 2011 Bridge Note financing agreed to extend the maturity date such that the December 2011 Bridge Notes were due on demand on or after January 31, 2013. The Company accounted for this amendment as a debt modification; accordingly, no gain or loss was recorded related to this modification.
	On April 5, 2013 the investors converted the outstanding principal of the December 2011 Bridge Notes, plus accrued interest, into 1,921,303 shares of the Company’s Series C Convertible Redeemable Preferred Stock and Warrants for the purchase of 19,213,030 shares of the Company’s Common Stock.
	Roenigk 2012 Convertible Promissory Note
	On June 20, 2012, the Company issued a Convertible Promissory Note dated April 1, 2012 in the principal amount of $1,877,217 to the Roenigk Family Trust in exchange for the 2007 Convertible Promissory Note and the 2008 Convertible Promissory Note discussed above (the “Old Notes”). The Note bears interest at the rate of 5% per annum from April 1, 2012 through May 31, 2012, then bears interest at the rate of 8% per annum until the maturity date, March 31, 2014. The principal amount and accrued interest on the Note is convertible into shares of Common Stock at a conversion price of $0.50 per share at any time at the election of the holder. Interest on the Note is payable semi-annually. The Company may, at its discretion, defer any scheduled interest payment until the maturity date of the Note upon payment of a $5,000 deferral fee. The Company added $161,000 and $67,000 of accrued interest to the principal balance of the Note during the years ended December 31, 2013 and 2012, respectively.  During the years ended December 31, 2013 and 2012, the Company recognized $84,000 and $153,000 in non-cash interest expense related to the amortization of the debt discount. The debt discount is being amortized over the term of the related convertible debt using the effective interest rate method.
	The exchange of the Old Notes for this Note has been accounted for as a troubled debt restructuring. The Company was granted a one year extension of the maturity date of the Old Notes, and the interest rate was increased from 5% to 8% per annum. The Company evaluated the anticipated future cash flows of this Note and determined that they exceed the carrying value (and accrued interest thereon) of the Old Notes. As a result, the Company did not record a loss or gain on this transaction.
	As further detailed in Note 14, on February 28, 2014 the Company entered into a Standstill Agreement with the Roenigk Family Trust and the holders of the August 2013 Bridge Notes (see Note 5), where the holders of these notes agreed not to commence enforcement, collection or similar proceedings with respect to these notes until May 1, 2014.

Equity

Equity	12 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	Note 7: Equity
	On March 20, 2013, the Company’s shareholders approved an amendment to the Certificate of Incorporation for the following purposes:
		·	To increase the number of authorized shares of Common Stock to 800,000,000 and to increase the number of authorized shares of Preferred Stock to 50,000,000;
		·	To reduce the number of shares of Preferred Stock designated as “Series B Convertible Preferred Stock” from 12,000,000 to 1,000,000 and to re-designate the remaining 11,000,000 shares heretofore designated as “Series B Convertible Preferred Stock” as “Series B-1 Convertible Preferred Stock”, with the shares in each sub-series having identical voting powers, designations, preferences and relative, participating, optional or other special rights, and qualifications, limitations and restrictions except that the shares of Series B-1 Convertible Preferred Stock shall have priority in liquidation; and
		·	To designate 15,000,000 shares of the previously authorized but undesignated shares of Preferred Stock as “Series C Convertible Redeemable Preferred Stock”.
	Shares of Series B-1 Convertible Preferred Stock are convertible, at any time at the discretion of the holder, into ten shares of the Company’s Common Stock.  Series B-1 Convertible Preferred Stock is identical to the Company’s Series B Convertible Preferred Stock in every respect except that holders of the Series B-1 Convertible Preferred Stock shall receive a liquidation preference equal to the Stated Value of their shares ($2.40 per share) plus all declared and unpaid dividends with respect thereto prior to any distribution to the holders of shares of Series B Convertible Preferred Stock.
	Shares of Series C Convertible Redeemable Preferred Stock are convertible, at any time at the discretion of the holder, into ten shares of the Company’s Common Stock, subject to conventional weighted-average anti-dilution adjustment in the event the Company issues or is deemed to have issued shares of Common Stock at a price less than $0.076 per share.
	The Company’s Board of Directors consists of seven members, four of whom are elected by holders of the Company’s Series B Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series C Convertible Redeemable Preferred Stock, and three who are elected by the holders of the Company’s Common Stock.
	The amendment to the Certificate of Incorporation became effective on April 5, 2013.
	Common Stock
	The Company issued 419,180 shares of Common Stock valued at $88,000 for services during 2012.
	On January 10, 2012, the Company entered into Warrant Amendment Agreements with six individuals who acquired warrants from five funds affiliated with Security Investors, LLC for the purchase of an aggregate of 5,633,344 shares of the Company’s Common Stock (collectively, the “Warrants”). Pursuant to the Warrant Amendment Agreements, the Company amended the Warrants to change the exercise prices from $0.30 per share to $0.095 per share, and the Investors agreed to exercise all of the Warrants immediately for cash. The Company received proceeds totaling $498,000, net of issuance costs, from the exercise of the Warrants.
	On February 10, 2012, the Company issued 419,180 shares of Common Stock to ARC Capital (BVI) Limited. (“ARC”) in partial consideration for financial advisory and other consulting services performed by ARC pursuant to a Financial Advisory and Consulting Agreement dated as of November 7, 2011. The value of this Common Stock was recorded as a component of general and administrative expense on the Company’s Consolidated Statement of Operations in the fourth quarter of 2011.
	On July 11, 2012, the Company entered into Securities Purchase Agreements (the “Agreements”) with twenty-four individuals and entities (the “Investors”) pursuant to which the Company issued an aggregate of 17,316,250 shares of Common Stock, Warrants for the purchase of an additional 18,670,375 shares of Common Stock at an exercise price of $0.15 per share and Warrants for the purchase of an additional 1,354,125 shares of Common Stock at an exercise price of $0.10 per share. The aggregate purchase price for the Shares and Warrants was $1,731,625, and the Company received proceeds of $1,565,908, net of issuance costs. The Warrants entitle the holders thereof to purchase shares of Common Stock at any time on or prior to July 11, 2017.
	On August 9, 2012, the Company entered into Securities Purchase Agreements (the “Agreements”) with eleven additional individuals and entities (the “Investors”) pursuant to which the Company issued an aggregate of 8,287,500 shares of Common Stock, Warrants for the purchase of an additional 9,116,250 shares of Common Stock at an exercise price of $0.15 per share and Warrants for the purchase of an additional 828,750 shares of Common Stock at an exercise price of $0.10 per share. The aggregate purchase price for the Shares and Warrants was $828,750, and the Company received proceeds of $729,068, net of issuance costs. The Warrants entitle the holders thereof to purchase shares of Common Stock at any time on or prior to July 11, 2017.
	On October 9, 2012, the Company entered into Securities Purchase Agreements (the “Agreements”) with nine additional individuals (the “Investors”) pursuant to which the Company issued an aggregate of 3,765,000 shares of Common Stock, Warrants for the purchase of an additional 4,141,500 shares of Common Stock at an exercise price of $0.15 per share and Warrants for the purchase of an additional 376,500 shares of Common Stock at an exercise price of $0.10 per share. The aggregate purchase price for the Shares and Warrants was $376,500, and the Company received proceeds of $331,196, net of issuance costs. The Warrants entitle the holders thereof to purchase shares of Common Stock at any time on or prior to July 11, 2017.
	The July, August and October Agreements described above include a price protection provision pursuant to which, at any time on or before January 11, 2014, the Company issues and sells any shares of Common Stock or securities convertible into Common Stock (“Convertible Securities”) at a price less than $0.10 per share (a “Dilutive Transaction”), the purchase price for the Shares shall automatically be reduced to a price equal to the price at which such shares were issued and sold (the “Reduced Price”) and the Company will issue to the Investors, for no additional consideration, a sufficient number of additional Shares so that the effective price per Share equals the Reduced Price. The Warrants include a similar price protection provision pursuant to which, upon a Dilutive Transaction, the exercise price of the Warrants shall automatically be reduced to a price equal to 150% of the Reduced Price. Upon such adjustment, the number of Warrant Shares issuable upon exercise of a Warrant shall automatically be adjusted by multiplying the number of shares issuable upon exercise of such Warrant immediately prior to the Dilutive Issuance by a fraction, (i) the numerator of which shall be the exercise price immediately prior to the Dilutive Issuance and (ii) the denominator of which shall be the exercise price as adjusted. See Note 8 for further discussion of the accounting treatment of these price protection revisions.
	In 2011, the Company requested certain holders of Common Stock Purchase Warrants to exercise such warrants or to surrender such warrants in exchange for shares of Common Stock. On April 5, 2013, the Company issued an aggregate of 6,031,577 shares of Common Stock as consideration for the surrender of Warrants for the purchase of an aggregate of 39,205,234 shares.
	Also, on April 5, 2013, the Company converted its December 2011 Bridge Notes and November 2012 Bridge Notes into shares of the Company’s Series C Convertible Redeemable Preferred Stock. Because the effective issuance price of the Series C Convertible Redeemable Preferred Stock was less than $0.10 per equivalent share of Common Stock, the Company issued to investors who purchased shares of the Company’s Common Stock and Warrants at closings on July 11, 2012, August 9, 2012 and October 9, 2012 (the “PIPE”), for no additional consideration, a sufficient number of additional shares of Common Stock so that the effective price per share of Common Stock paid by the PIPE Investors equals the effective issuance price of the shares of Series C Convertible Redeemable Preferred Stock on an as-converted basis ($0.076 per share). Accordingly, on April 5, 2013, the Company issued a total of 9,274,364 shares of Common Stock to the PIPE Investors.
	At December 31, 2013, approximately 426 million shares of Common Stock were reserved for future issuance under convertible debt and warrant agreements, stock option arrangements and other commitments.
	Preferred Stock
	As of December 31, 2013 and 2012, the Company has 208,334 shares of Series A Convertible Preferred Stock outstanding, which is held by a single investor. Each share of Series A Convertible Preferred Stock is convertible into one share of the Company’s Common Stock and has a liquidation value of $1.20 per share.
	The Company designated and began issuing shares of its Series B Convertible Preferred Stock in 2009. Each share of the Company’s Series B Convertible Preferred Stock is convertible, at any time at the discretion of the holder, into ten shares of the Company’s Common Stock.
	As an inducement to effect the transactions on April 5, 2013 as detailed below, the Company agreed to allow such holders to exchange shares of Series B Convertible Preferred Stock for an equal number of shares of Series B-1 Convertible Preferred Stock. Accordingly, on April 5, 2013 the Company issued an aggregate of 8,839,500 shares of Series B-1 Convertible Preferred Stock in exchange for an equal number of shares of Series B Convertible Preferred Stock. The surrendered shares of Series B Convertible Preferred Stock were cancelled and are no longer outstanding.
	Redeemable Preferred Stock
	As stated above, shares of Series C Convertible Redeemable Preferred Stock are convertible, at any time at the discretion of the holder, into ten shares of the Company’s Common Stock, subject to conventional weighted-average anti-dilution adjustment in the event the Company issues or is deemed to have issued shares of Common Stock at a price less than $0.076 per share.
	As detailed in Notes 5 and 6, on April 5, 2013, holders of the Company’s December 2011 Bridge Notes and the Company’s November 2012 Bridge Notes exchanged such notes with an aggregate principal amount of $4,950,000 plus accrued interest totaling $314,177 for a total of 6,926,553 shares of the Company’s Series C Convertible Redeemable Preferred Stock and Warrants for the purchase of a total of 69,265,530 shares of Common Stock.
	The effective price of the Series C Convertible Redeemable Preferred Stock was $0.76 per share (or $0.076 per equivalent share of Common Stock). The Warrants entitle the holders to purchase, at any time on or before April 5, 2018, shares of Common Stock at an exercise price of $0.114 per share. The Warrants contain other conventional terms, including provisions for adjustment in the exercise price and/or the securities issuable upon exercise in the event of certain specified extraordinary corporate events, such as stock splits, combinations, and stock dividends.
	As additional consideration to the investors for their participation in the Bridge Note issuances mentioned above, for each $100 of principal and interest converted into Series C Convertible Redeemable Preferred Stock and Warrants, each Investor exchanged 41.67 shares of Series B Convertible Preferred Stock held for 131.58 additional shares of Series C Convertible Redeemable Preferred Stock (the number of shares of Series C Convertible Redeemable Preferred Stock that would be purchased for $100 at a purchase price of $0.76 per share). Accordingly, the Company issued an aggregate of 6,926,553 additional shares of Series C Convertible Redeemable Preferred Stock in exchange for an aggregate of 2,193,414 previously-outstanding shares of Series B Convertible Preferred Stock. The additional shares of Series C Convertible Redeemable Preferred Stock were issued without warrant coverage. The shares of Series B Convertible Preferred Stock surrendered were cancelled and are no longer outstanding.
	The Series C Convertible Redeemable Preferred Stock will be redeemable, at a price equal to $0.76 per share, plus all accrued and unpaid dividends thereon, at the election of the holders of 66-?% of the then-outstanding shares, in three equal annual installments on or after December 31, 2017. As of December 31, 2013, redemption requirements of the Series C Convertible Redeemable Preferred Stock would be approximately $3,509,500 in each of the years 2017, 2018 and 2019. The Company has elected not to accrete the Series C Redeemable Convertible Preferred Stock to its redemption value over the redemption period due to the low likelihood of redemption by the holders of this series of stock.
	Because of this redemption feature, this class of preferred stock is recorded at its issuance date fair value and is classified as mezzanine equity on the Company’s Consolidated Balance Sheet at December 31, 2013.
	Stock Options
	The Company’s 1997 Stock Option Plan (the “Plan”) provided for incentive and non-incentive stock options for an aggregate of 750,000 shares of Common Stock for key employees and non-employee Directors of the Company. The Plan, which expired on December 31, 2007, provided that the exercise price of each option must be at least equal to 100% of the fair market value of the Common Stock on the date of grant. The Plan contained automatic grant provisions for non-employee Directors of the Company.
	The ThermoEnergy Corporation 2008 Incentive Stock Plan (the “2008 Plan”) provides for the granting of non-qualified stock options, restricted stock, stock appreciation rights (“SAR”) and incentive stock options for officers, employees, non-employee members of the Board of Directors, consultants and other service providers.  Options may not be granted at an exercise price less than the fair market value of the Company’s Common Stock on the date of grant and the term of the options may not be in excess of ten years.  On March 20, 2013 the Company’s shareholders approved an amendment to the 2008 Plan to increase the number of shares reserved from 20,000,000 shares to 40,000,000.
	Although the granting of awards under the 2008 Plan is generally at the discretion of the Compensation Committee of the Board of Directors, the 2008 Plan provides for automatic grants of stock options to the non-employee members of the Board of Directors. Each non-employee Director who is elected or appointed to the Board for the first time shall automatically be granted a non-qualified stock option to purchase 30,000 shares of the Company’s Common Stock. Thereafter, at each subsequent Annual Meeting of Stockholders, each non-employee Director who is re-elected to the Board of Directors or continues to serve a term that has not expired will receive a non-qualified stock option grant to purchase an additional 30,000 shares. All options granted to non-employee Directors vest and become fully exercisable on the date of the first Annual Meeting of Stockholders occurring after the end of the fiscal year of the Company during which such option was granted and shall have a term of ten years. On March 20, 2013 the Company’s shareholders approved an amendment to the 2008 Plan to increase the number of shares granted to non-employee Directors to 100,000.
	The following table presents non-cash stock option expense included in expenses in the Company’s Consolidated Statements of Operations for the years ended December 31, 2013 and 2012 (in thousands):
			2013			2012
	Cost of revenue		$	—		$	4
	General and administrative			223			548
	Engineering, research and development			26			77
	Sales and marketing			6			126
	Option expense before tax			255			755
	Income tax benefit			—			—
	Net option expense		$	255		$	755
	During 2013, the Board of Directors awarded officers and various members of the Board of Directors a total of 14,450,000 stock options.  The options are exercisable at exercise prices ranging from $0.0468 to $0.089 per share for a ten year period. The exercise price was equal to or greater than the market price on the respective grant dates during the year.
	During 2012, the Board of Directors awarded officers, employees, and various members of the Board of Directors a total of 7,560,000 stock options.  The options are exercisable at exercise prices ranging from $0.085 to $0.268 per share for a ten year period. The exercise price was equal to or greater than the market price on the respective grant dates during the year.
	The fair value of options granted during 2013 and 2012 were estimated at the date of grant using the Black-Scholes option pricing model with the following assumptions:
			2013		2012
	Risk-free interest rate		0.92% - 1.07%		0.83% - 2.23%
	Expected option life (years)		6.25		6.25 – 10.0
	Expected volatility		90% - 91%		90% - 92%
	Expected dividend rate		0%		0%
	The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods over the expected life of the option. The expected option life represents the weighted average period of time that options granted are expected to be outstanding giving consideration to vesting schedules and the Company’s historical exercise patterns. Expected volatility is based on the historical volatility of the Company’s common stock over the expected life of the option granted.
	Option expense for the years ended December 31, 2013 and 2012 was calculated using an expected forfeiture rate of 5%.
	A summary of the Company’s stock option activity and related information for the years ended December 31, 2013 and 2012 follows:
			2013					2012
			Number of		Wtd. Avg.			Number of	Wtd. Avg.
			Shares		Price per			Shares	Price per
					Share				Share
	Outstanding, beginning of year		24,896,678		$	0.32		19,674,102	$	0.38
	Granted		14,450,000		$	0.09		7,560,000	$	0.16
	Canceled and expired		-7,838,601		$	0.28		-2,337,424	$	0.29
	Outstanding, end of year		31,508,077		$	0.22		24,896,678	$	0.32
Vested and exercisable, end of year		17,254,952		$	0.33		14,700,574	$	0.4
The weighted average grant date fair value of options granted were $0.065 per share and $0.11 per share for the years ended December 31, 2013 and 2012, respectively. The total fair value of options vested were approximately $499,000 and $1,137,000 as of December 31, 2013 and 2012, respectively. Options vested and expected to vest are not meaningful as of December 31, 2013 and 2012, as the price of the Company’s stock would not allow the holders to reasonably exercise these options.
Exercise prices for options outstanding as of December 31, 2013 ranged from $0.0468 to $1.50. The weighted average remaining contractual life of those options was approximately 7.7 years at December 31, 2013. The weighted average remaining contractual life of options vested and exercisable was approximately 6.7 years at December 31, 2013.
As of December 31, 2013, there was $568,000 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Company’s stock option plans.  That cost is expected to be recognized over a weighted-average period of 1.5 years.  The Company recognizes stock-based compensation on the graded-vesting method.
Warrants
At December 31, 2013, there were outstanding warrants for the purchase of 137,631,302 shares of the Company’s Common Stock at prices ranging from $0.10 per share to $0.55 per share (weighted average exercise price was $0.15 per share). The expiration dates of outstanding warrants as of December 31, 2013 are as follows:
Expiration		Warrants
		Outstanding
2014		1,531,103
2015		296,293
2016		20,625,815
2017		44,570,061
2018		69,265,530
2019 and later		1,342,500
		137,631,302

Derivative_Liabilities

Derivative Liabilities	12 Months Ended
	Dec. 31, 2013
Derivative Liability [Abstract]	'
Derivative Liabilities [Text Block]	'
	Note 8: Derivative Liabilities
	The Company has periodically issued Common Stock and Common Stock purchase warrants with anti-dilution provisions as additional consideration with certain debt instruments. Additionally, certain debt instruments have been convertible into shares of the Company’s Series C Convertible Redeemable Preferred Stock, which are convertible into shares of the Company’s Common Stock and have anti-dilution provisions and liquidation preferences. Because these instruments contain provisions that are not indexed to the Company’s stock, the Company is required to record these as derivative instruments.
	Assets and liabilities measured at fair value on a recurring basis as of December 31, 2013 are as follows: (in thousands)
				Fair Value Measurements at Reporting Date Using
	Description	Balance as of		Quoted Prices		Significant		Significant
		December 31,		in Active		Other		Unobservable
		2013		Markets for		Observable		Inputs
				Identical		Inputs		(Level 3)
				Assets		(Level 2)
				(Level 1)
	Liabilities
	Derivative liability – long-term portion	$	186	$	-	$	-	$	186
	Total	$	186	$	-	$	-	$	186
	During 2013, as discussed in Note 6, the Company’s December 2011 Bridge Notes and November 2012 Bridge Notes were converted into shares of the Company’s Series C Convertible Redeemable Preferred Stock at a rate of $0.76 per share. Additionally, as discussed in Note 7, the investors in these notes were allowed to exchange an equal value of Series B Convertible Preferred Stock into shares of Series C Convertible Redeemable Preferred Stock. The Series C Convertible Redeemable Preferred Stock is convertible into 10 shares of the Company’s Common Stock at any time. The Series C Convertible Redeemable Preferred Stock also contains anti-dilution provisions that allow for a reduction on the conversion price in the event of a future financing at an exercise price lower than the conversion price of the Preferred Stock and contains liquidation preferences to the holder. Because these provisions in the Series C Convertible Redeemable Preferred Stock are not indexed to the Company’s Common Stock, the value of these conversion features must be bifurcated and treated as derivative liabilities. As a result, the Company recorded derivative liabilities totaling $607,000 in the second quarter of 2013.
	The fair value of these derivative liabilities as of December 31, 2013 was $186,000, which are classified as long-term liabilities on the Company’s Consolidated Balance Sheets. The Monte Carlo Simulation lattice model was used to determine the fair values at December 31, 2013. The significant assumptions used were: exercise price of $0.076; the Company’s stock price on December 31, 2013, $0.029; expected volatility of 70%; risk free interest rate between 0.04% and 1.39%; a remaining contract term between 2 and 51 months; and probability of financing options and effects on the Company’s capitalization.
	The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of issuance for periods over the expected life of the derivative. Expected volatility is based on the historical volatility of the Company’s common stock over the expected term of the derivative.
	The decrease in fair value of the Company’s derivative liabilities resulted in income of $2,357,000 for the year ended December 31, 2013. The income results primarily from the passage of time, decreases in the Company’s stock price and the probability of financing options and effects on the Company’s capitalization.
	Assets and liabilities measured at fair value on a recurring basis as of December 31, 2012 are as follows: (in thousands)
				Fair Value Measurements at Reporting Date Using
	Description	Balance as of		Quoted Prices		Significant		Significant
		December 31,		in Active		Other		Unobservable
		2012		Markets for		Observable		Inputs
				Identical		Inputs		(Level 3)
				Assets		(Level 2)
				(Level 1)
	Liabilities
	Derivative liability – current portion	$	20	$	-	$	-	$	20
	Derivative liability – long-term portion		2,214		-		-		2,214
	Total	$	2,234	$	-	$	-	$	2,234
	As part of the financing transactions in July, August and October 2012 as discussed in Note 7, if the Company issues and sells any shares of Common Stock or securities convertible into Common Stock (“Convertible Securities”) at a price less than $0.10 per share at any time on or before January 11, 2014 (a “Dilutive Transaction”), the purchase price for the shares shall automatically be reduced to a price equal to the price at which such shares were issued and sold (the “Reduced Price”), and the Company will issue to the Investors, for no additional consideration, a sufficient number of additional shares so that the effective price per share equals the Reduced Price.
	The Warrants include a similar price protection provision pursuant to which, upon a Dilutive Transaction, the exercise price of the Warrants shall automatically be reduced to a price equal to 150% of the Reduced Price. Upon such adjustment, the number of shares issuable upon exercise shall automatically be adjusted by multiplying the number of shares issuable upon exercise of such warrant immediately prior to the Dilutive Transaction by a fraction, (i) the numerator of which shall be the exercise price immediately prior to the Dilutive Transaction and (ii) the denominator of which shall be the exercise price as adjusted.
	Because these provisions as described above are not indexed to the Company’s Common Stock, the value of the anti-dilution features of the Common Stock and the value of the Warrants must be bifurcated and treated as derivative liabilities. As a result, the Company initially recorded derivative liabilities totaling $3,064,000 in the third and fourth quarters of 2012. Because the Company recorded derivative liabilities that exceeded the proceeds received, the Company recorded a charge of approximately $567,000. This amount is recorded as other derivative expense on the Company’s Consolidated Statement of Operations for the year ended December 31, 2012.
	The fair value of these derivative liabilities as of December 31, 2012 was $2,234,000, of which derivative liabilities with an aggregate value of $20,000 expire in one year or less and are classified as current liabilities on the Company’s Consolidated Balance Sheets. The Monte Carlo Simulation lattice model was used to determine the fair values at December 31, 2012. The significant assumptions used were: exercise prices between $0.10 and $0.36; the Company’s stock price on December 31, 2012, $0.09; expected volatility of 55% - 75%; risk free interest rate between 0.16% and 0.72%; and a remaining contract term between 5 months and 55 months.
	The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of issuance for periods over the expected life of the derivative. Expected volatility is based on the historical volatility of the Company’s common stock over the expected term of the derivative.
	The decrease in fair value of the Company’s derivative liabilities resulted in income of $1,637,000 for the year ended December 31, 2012. The income results primarily from the passage of time and decreases in the Company’s stock price.
	The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liabilities classified as Level 3 for the years ended December 31, 2013 and 2012 (in thousands):
		2013		2012
	Balance at beginning of year	$	2,234	$	807
	Recognition of derivative liabilities		607		3,064
	Exercise of derivative instruments		-298		—
	Change in fair value		-2,357		-1,637
		$	186	$	2,234

Related_party_transactions

Related party transactions	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	Note 9: Related party transactions
	The Company has an 85% ownership interest in ThermoEnergy Power Systems, LLC, a Delaware limited liability company (“TEPS”) for the purpose of transferring the Company’s rights and interests in its pressurized oxycombustion technology. Alexander Fassbender, the Company’s former Executive Vice President and Chief Technology Officer, as the inventor of the technology, has a 7.5% ownership interest, and the remaining 7.5% is owned by an unrelated third party. Accordingly, the Company records the value of the noncontrolling interest on the Company’s Consolidated Balance Sheets, which totaled $0 and $2,000 as of December 31, 2013 and 2012, respectively.
	See Note 4 for detailed information on UPA, a joint venture in which the Company has a 50% ownership stake.
	The Company has employment agreements with certain of its officers that specify base compensation, stock options and lump sum payment amounts in the event of a change in control of the Company.
	See Notes 5 and 6 for additional related party transactions.

Income_taxes

Income taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	Note 10: Income taxes
	The Company has not recorded a provision for income taxes, as the Company has historically incurred operating losses and maintains a full valuation allowance against its net deferred tax assets. The reported amount of income tax expense for the years differs from the amount that would result from applying domestic federal statutory tax rates to pretax losses primarily because of changes in the valuation allowance.
	Management has considered the Company’s history of losses and concluded that it is more likely than not that the Company will not recognize the benefits of federal and state deferred tax assets. Accordingly, a full valuation allowance of approximately $24.5 million and $25.4 million has been established as of December 31, 2013 and 2012, respectively.
	Significant components of the Company's deferred tax assets are as follows as of December 31, 2013 and 2012 (in thousands):
		2013		2012
	Net operating loss carryforwards	$	22,071	$	22,114
	Derivative liabilities		-48		849
	Stock options and warrants		2,227		2,140
	Valuation discount		-9		-40
	Other		251		352
			24,492		25,415
	Valuation allowance – deferred tax assets		-24,492		-25,415
		$	-	$	-
	A reconciliation of income tax expense (benefit) at the statutory rate to income tax expense at the Company's effective rate is shown below for the years ended December 31, 2013 and 2012 (in thousands):
		2013		2012
	Computed at statutory rate (34%)	$	-549	$	-2,510
	(Decrease) increase in valuation allowance for deferred tax assets		495		3,130
	Stock and stock options		81		130
	Derivative liabilities		—		-849
	Non-deductible items and other		-27		99
	Benefit for income taxes	$	-	$	-
	At December 31, 2013, the Company has net operating loss carryforwards, which expire in various amounts during 2014 through 2033, of approximately $62.2 million.    Utilization of net operating losses and research and development credit carryforwards may be subject to a substantial annual limitation under Section 382 of the Internal Revenue Code of 1986 due to ownership change limitations that have occurred previously or that could occur in the future. These ownership changes may limit the amount of net operating losses and research and development credit carryforwards that can be utilized annually to offset future taxable income and tax, respectively. Additionally, the Internal Revenue Code provides for limitations on the use of net operating loss carryforwards for acquired entities. The Company’s annual limitation for the use of CASTion’s net operating loss carryforwards for periods prior to the date of acquisition for income tax reporting purposes is approximately $300,000.
	As further discussed in Note 13, the Company has agreed, in conjunction with the Offer in Compromise accepted by the IRS in March 2011, that any net operating losses sustained for the years ending December 31, 2010 through December 31, 2012 will not be claimed as deductions under the provisions of Section 172 of the Internal Revenue Code except to the extent that such net operating losses exceed the amount of interest and penalties abated, which totaled $2,263,000.

Employee_benefit_plans

Employee benefit plans	12 Months Ended
	Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
Compensation and Employee Benefit Plans [Text Block]	'
	Note 11: Employee benefit plans
	The Company has adopted an Employee Stock Ownership Plan. However, as of December 31, 2013, the Plan had not been funded nor submitted to the Internal Revenue Service for approval. The Company has a 401(k) Plan, but no employer contributions have been made to date.

Segments

Segments	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
	Note 12: Segments
	Operating segments are identified as components of an enterprise about which separate discrete financial information is available to the chief operating decision maker, or decision-making group, in assessing performance and allocating resources. As stated in Note 1, the Company markets and develops advanced municipal and industrial wastewater treatment and carbon reducing clean energy technologies. The Company currently generates its revenues from the sale and service of its wastewater treatment systems and from its contract with UPA. The Company’s efforts to develop and commercialize its clean energy technologies are discussed in Note 4. Separate disclosure of financial information related to the Company’s clean energy technologies is not required, as all operating activity is captured in the Company’s joint venture. The financial information presented in these financial statements represents all the material financial information related to the Company’s water treatment technologies as the sole reportable segment.
	The Company’s operations are currently conducted solely in the United States. Approximately 74% and 91% of the Company’s revenues came from customers in the United States in 2013 and 2012, respectively; the remainder of its revenues in 2013 and 2012 came from customers in Asia. The Company will continue to evaluate how its business is managed and, as necessary, adjust the segment reporting accordingly.

Commitments_and_contingencies

Commitments and contingencies	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	Note 13: Commitments and contingencies
	The Company leases its primary facility in Worcester, MA under an operating lease with an unaffiliated third party which expires in January 2017. The following table summarizes the Company’s operating lease commitments on its primary facility at December 31, 2013: (in thousands)
	Payments due in:	Amount
	2014	$	178
	2015		183
	2016		188
	2017		16
		$	565
	The Company recognized rent expense of $173,000 and $168,000 related to this lease agreement for the years ended December 31, 2013 and 2012, respectively.
	On March 25, 2011, the Company was notified by the U.S. Internal Revenue Service that it had accepted the Company’s Offer in Compromise with respect to its tax liabilities relating to (i) employee tax withholding for all periods commencing with the quarter ended September 30, 2005 and continuing through September 30, 2009 and (ii) federal unemployment taxes (FUTA) for the years 2005 through 2008 that were not paid by the Company’s former Chief Financial Officer. Pursuant to the Offer in Compromise, it has agreed to satisfy its delinquent tax liabilities by paying a total of $2,134,636 (representing the aggregate amount of tax due, without interest or penalties). The Company made its final payment of $176,636 in January 2012. In connection with the Offer in Compromise, the Company has agreed that any net operating losses sustained for the years ending December 31, 2010 through December 31, 2012 will not be claimed as deductions under the provisions of Section 172 of the Internal Revenue Code except to the extent that such net operating losses exceed the amount of interest and penalties abated. The IRS acceptance of the Offer in Compromise is conditioned, among other things, on the Company filing and paying all required taxes for five tax years commencing on the date of the IRS acceptance.
	Accrued payroll taxes, which includes penalties and interest related to state taxing authorities, totaled $399,000 as of December 31, 2013 and 2012.
	The Company is involved from time to time in litigation incidental to the conduct of its business. Judgments could be rendered or settlements entered that could adversely affect the Company’s operating results or cash flows in a particular period. The Company routinely assesses all of its litigation and threatened litigation as to the probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

Subsequent_Event

Subsequent Event	12 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	Note 14: Subsequent Event
	On February 28, 2014, the Company entered into a Standstill Agreement (the “Standstill Agreement”) with The Roenigk Family Trust dated November 10, 2004 (“Roenigk”), Robert S. Trump (“Trump”) and Empire Capital Partners, L.P., Empire Capital Partners, Ltd., Empire Capital Partners Enhanced Master Fund, Ltd. (collectively, “Empire” and, together with Roenigk and Trump, the “Creditors”) who hold promissory notes issued in the aggregate principal amount of $5,877,217.12 (the “Notes”). The Company’s obligations under the Notes held by Trump and Empire are secured by a first priority security interest in substantially all of the Company’s assets (the “Collateral”) pursuant to a Security Agreement dated as of August 22, 2013 (the “Security Agreement”).
	Pursuant to the Standstill Agreement, the Creditors agreed that, subject to certain exceptions, from the date of the Standstill Agreement until May 1, 2014 (the “Forbearance Period”), notwithstanding the maturity of any of the Notes nor the occurrence or continuance of any Event of Default under any of the Notes or under the Security Agreement, none of the Creditors shall commence enforcement, collection or similar proceedings with respect to any of the Notes or the Collateral or exercise any other rights or remedies any of the Creditors may have under the Notes or the Security Agreement or otherwise, at law or in equity, with respect to the Company’s obligations under the Notes or the Security Agreement. The Creditors have not waived any of their rights under the Notes or the Security Agreement and, during the Forbearance Period, interest will continue to accrue on the Notes in accordance with their terms.

Organization_and_summary_of_si1

Organization and summary of significant accounting policies (Policies)	12 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Nature of Operations [Text Block]	'
	Nature of business
	ThermoEnergy Corporation (“the Company”) was incorporated in January 1988 for the purpose of developing and marketing advanced municipal and industrial wastewater treatment and carbon reducing power generation technologies.
	The Company’s wastewater treatment systems are based on its proprietary Controlled Atmosphere Separation Technology (“CAST®”) platform.  The Company’s patented and proprietary platform technology is combined with off-the-shelf technologies to provide systems that are inexpensive, easy to operate and reliable. The Company’s wastewater treatment systems have global applications in metal finishing, heavy manufacturing, hydraulic fracturing, petrochemical, refining, aerospace, food and beverage processing, pulp and paper, microchip and circuit board manufacturing and municipal wastewater. The CAST® platform technology is owned by its subsidiary, CASTion Corporation (“CASTion”).
	The Company also owns a patented pressurized oxycombustion technology that converts fossil fuels (including coal, oil and natural gas) and biomass into electricity while producing near zero air emissions and removing and capturing carbon dioxide in liquid form for sequestration or beneficial reuse. This technology is intended to be used to build new or to retrofit old fossil fuel power plants globally with near zero air emissions while capturing carbon dioxide as a liquid for ready sequestration far more economically than any other competing technology. The pressurized oxycombustion  technology is held in the Company’s subsidiary, ThermoEnergy Power Systems, LLC (“TEPS”).
	The Company’s pressurized oxycombustion technology and the water technologies are collectively referred to as the “Technologies.”
Principles Of Consolidation and Basis Of Presentation [Policy Text Block]	'
	Principles of consolidation and basis of presentation
	The consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Financial results for Unity Power Alliance (“UPA”) have been consolidated for the period from inception until the date it became a Joint Venture on July 16, 2012. Financial results for UPA as a Joint Venture are accounted for under the equity method of accounting for investments, as discussed in Note 4.
	Certain prior year amounts have been reclassified to conform to current year classifications. The Company separated the balance of accrued payroll and other taxes from other current liabilities; these amounts were included as part of other current liabilities on the Company’s Consolidated Balance Sheet as of December 31, 2012. Additionally, the Company reduced its balance of notes receivable, with an offsetting reduction of long term liabilities, by $100,000 compared to amounts reports on the Company’s Consolidated Balance Sheet as of December 31, 2012 to consistently report activity related to its investments in UPA.
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates affecting amounts reported in the consolidated financial statements relate to revenue recognition, recognition of derivative liabilities and accruals for payroll and other taxes.
	The 15% third party ownership interest in TEPS is recorded as a noncontrolling interest in the consolidated financial statements.
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue recognition
	Historically, the Company has recognized revenues using the percentage-of-completion method. Under this approach, revenue is earned in proportion to total costs incurred in relation to total costs expected to be incurred. Project costs include all direct material and labor costs and indirect costs related to project performance, such as indirect labor, supplies, tools, repairs and depreciation.
	Recognition of revenue and profit under the percentage-of-completion method is dependent upon a number of factors, including the accuracy of a variety of estimates made at the balance sheet date such as engineering progress, materials quantities, as well as achievement of milestones, penalty provisions, labor productivity and cost estimates made. Due to uncertainties inherent in the estimation process, actual completion costs may vary from estimates. Changes in job performance, job conditions and estimated profitability may result in revisions to costs and income and are recognized beginning in the period in which they become known. Provisions for estimated losses on uncompleted contracts are made in the period in which the estimated loss first becomes known.
	Certain long-term projects include a number of different services to be provided to the customer. The Company records separately revenues, costs and gross profit related to each of these services if they meet the contract segmenting criteria.
	In circumstances when the Company cannot estimate the final outcome of a project, or when the Company cannot reasonably estimate revenue, the Company utilizes the percentage-of-completion method based on a zero profit margin until more precise estimates can be made. If and when the Company can make more precise estimates, revenues are adjusted accordingly and recorded as a change in an accounting estimate. The Company recorded revenue from one project which represented 21% and less than 1% of its revenues for the years ended December 31, 2013 and 2012, respectively, utilizing the percentage of completion method based on a zero profit margin.
	Effective October 1, 2013, the Company launched changes to its operations to emphasize standardized systems and manufacturing processes and has commenced selling wastewater treatment systems based on these changes. The Company recognizes revenue on the sale of its wastewater treatment systems from this new standardized process at the point of shipment or transfer of title, provided there is persuasive evidence of an arrangement, the fee is fixed and determinable, and the collectability of the related receivable is probable. Amounts received from customers in advance of shipment are recorded within customer deposits.
	The Company recognizes revenues on its contract with UPA on a time-and-materials basis.
	Revenue from spare parts sales is recognized upon shipment or title transfer under the terms of the customer contract.
	Service revenue is recognized upon the completion and acceptance of the work performed.
Consolidation, Variable Interest Entity, Policy [Policy Text Block]	'
	Variable interest entities
	The Company assesses whether its involvement with another related entity constitutes a variable interest entity (“VIE”) through either direct or indirect variable interest in that entity. If an entity is deemed to be a VIE, the Company must determine if it is the primary beneficiary (i.e. the party that consolidates the VIE), in accordance with the accounting standard for the consolidation of variable interest entities. The Company qualitatively evaluates if it is the primary beneficiary of the VIE’s based on whether the Company has (i) the power to direct those matters that most significantly impacted the activities of the VIE; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE. See Note 4 for further discussion of UPA as a variable interest entity.
Cash and Cash Equivalents, Policy [Policy Text Block]	'
	Cash and cash equivalents
	The Company places its cash in highly rated financial institutions, which are continually reviewed by senior management for financial stability. Generally the Company’s cash in interest-bearing accounts exceeds financial depository insurance limits. However, the Company has not experienced any losses in such accounts and believes that its cash is not exposed to significant credit risk.
	The Company has a cash management program which provides for the investment of excess cash balances primarily in money market funds, which are valued using Level 1 inputs. The Company considers such highly liquid investments with original maturities of three months or less when purchased to be cash equivalents.
Receivables, Policy [Policy Text Block]	'
	Accounts receivable, net
	Accounts receivable are recorded at their estimated net realizable value. Receivables related to the Company’s contracts have realization and liquidation periods of less than one year and are therefore classified as current.
	The Company maintains allowances for specific doubtful accounts based on estimates of losses resulting from the inability of customers to make required payments and record these allowances as a charge to general and administrative expense. The Company’s method for estimating its allowance for doubtful accounts is based on judgmental factors, including known and inherent risks in the underlying balances, adverse situations that may affect the customer’s ability to pay and current economic conditions. Amounts considered uncollectible are written off based on the specific customer balance outstanding.
	The following is a summary of the Company’s allowance for doubtful accounts activity for the year ended December 31, 2013: (in thousands)
	Allowance for doubtful accounts, beginning of year		$	—
	Bad debt expense			5
	Write-offs			-5
	Allowance for doubtful accounts, end of year		$	—
	The Company did not have any activity in its allowance for doubtful accounts for the year ended December 31, 2012.
	At December 31, 2013, two customers accounted for 81% of the Company’s total accounts receivable balance. At December 31, 2012, one customer accounted for 53% of the Company’s accounts receivable balance. For the year ended December 31, 2013, three customers each accounted for more than 10% of the Company’s revenues and collectively accounted for 76% of total revenues. For the year ended December 31, 2012, one customer accounted for 73% of the Company’s revenues.
Inventory, Policy [Policy Text Block]	'
	Inventories, net
	Inventories are stated at the lower of cost or net realizable value using the first-in, first-out method and are comprised of the following as of December 31, 2013 and 2012: (in thousands)
			2013			2012
	Raw materials		$	192		$	187
	Work in process			46			—
				238		$	187
	Less: Reserve for excess and obsolete inventory			-134			-134
			$	104		$	53
	The Company evaluates its inventory for excess quantities and obsolescence on a periodic basis.  In preparing its evaluation, the Company looks at the expected demand for its products for the next three to twelve months.  Based on this evaluation, the Company records provisions to ensure that inventory is appropriately stated at the lower of cost or net realizable value.
Property, Plant and Equipment, Policy [Policy Text Block]	'
	Property and equipment
	Property and equipment are stated at cost and are depreciated over the estimated useful life of each asset. Depreciation is computed using the straight-line method.  Property and equipment are comprised of the following as of December 31, 2013 and 2012: (in thousands)
			Estimated Useful Lives		2013			2012
	Computers and software		3-5 years		$	254		$	198
	Furniture and fixtures		7 years			50			50
	Demonstration equipment		7 years			464			604
	Leasehold improvements		life of lease			168			110
	Production and laboratory equipment		7 years			126			126
						1,062		$	1,088
	Less: Accumulated depreciation					-469			-420
					$	593		$	668
	Depreciation expense was $189,000 and $119,000 for the years ended December 31, 2013 and 2012, respectively.
	The Company evaluates long-lived assets based on estimated future undiscounted net cash flows or other fair value measures whenever significant events or changes in circumstances occur that indicate the carrying amount may not be recoverable. If that evaluation indicates that an impairment has occurred, a charge is recognized to the extent the carrying amount exceeds the undiscounted cash flows or fair values of the asset, whichever is more readily determinable.
	The Company recorded a loss of $131,000 in 2012 related to the disposal of a system previously used for pre-sales testing. This loss is included in sales and marketing expense on its Consolidated Statement of Operations for the year ended December 31, 2012.
Regulatory Income Taxes, Policy [Policy Text Block]	'
	Taxes to governmental authorities
	The Company collects sales taxes but excludes such amounts from revenues.
Shipping and Handling Cost, Policy [Policy Text Block]	'
	Shipping and handling costs
	Shipping and handling costs that are billed to customers are included in cost of goods sold in the accompanying statements of operations.
Advertising Costs, Policy [Policy Text Block]	'
	Advertising costs
	The Company expenses advertising costs as incurred. During the years ended December 31, 2013 and 2012, the Company incurred advertising expense in the amounts of $27,000 and $37,000, respectively.
Commitments and Contingencies, Policy [Policy Text Block]	'
	Contingencies
	The Company accrues for costs relating to litigation, including litigation defense costs, claims and other contingent matters, including liquidated damage liabilities, when such liabilities become probable and reasonably estimable. Such estimates may be based on advice from third parties or on management’s judgment, as appropriate. Revisions to payroll tax and other accruals are reflected in income in the period in which different facts or information become known or circumstances change that affect the Company’s previous assumptions with respect to the likelihood or amount of loss. Amounts paid upon the ultimate resolution of contingent liabilities may be materially different from previous estimates and could require adjustments to the estimated liability to be recognized in the period such new information becomes known.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	Stock options
	The Company accounts for stock options in accordance with Accounting Standards Codification (“ASC”) Topic 718, “Compensation – Stock Compensation.” This topic requires that the cost of all share-based payments to employees, including grants of employee stock options, be recognized in the financial statements based on their fair values on the measurement date, which is generally the date of grant.  Such cost is recognized over the vesting period of the awards.  The Company uses the Black-Scholes option pricing model to estimate the fair value of “plain vanilla” stock option awards.
Income Tax, Policy [Policy Text Block]	'
	Income taxes
	The Company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax basis of assets and liabilities and are measured using enacted rates and laws that will be in effect when the deferred tax assets or liabilities are expected to be realized or settled. A valuation allowance for deferred tax assets is provided if it is more likely than not that all or a portion of the deferred tax assets will not be realized. The Company recognizes interest and penalties related to underpayments of income taxes as a component of interest and other expense on its Consolidated Statement of Operations.
	The Company estimates contingent income tax liabilities based on the guidance for accounting for uncertain tax positions as prescribed in ASC Topic 740, “Income Taxes.” The Company uses a two-step process to assess each income tax position.  It first determines whether it is more likely than not that the income tax position will be sustained, based on technical merits, upon examination by the taxing authorities.  If the income tax position is expected to meet the more likely than not criteria, the Company then records the benefit in the financial statements that equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement.  At December 31, 2013 and 2012, there are no uncertain tax positions that require accrual.
	The Company is subject to taxation in the U.S. and various states. As of December 31, 2013 the Company’s tax years for 2010, 2011, 2012 and 2013 are subject to examination by the tax authorities. As of December 31, 2013, the Company is no longer subject to U.S. federal, state or local examinations by tax authorities for years before 2010. Tax year 2009 was open as of December 31, 2012.
Fair Value of Financial Instruments, Policy [Policy Text Block]	'
	Fair value of financial instruments and fair value measurements
	The carrying amount of cash and cash equivalents, accounts receivable, other current assets, accounts payable, short term borrowings and other current liabilities in the consolidated financial statements approximate fair value because of the short-term nature of those instruments. The carrying amount of the Company’s convertible debt and short term borrowings was $6,083,000 and $7,279,000 at December 31, 2013 and 2012, respectively, and approximates its fair value, as the interest rate on this debt approximates the interest rate of the Company’s recent borrowings. The Company’s derivative liabilities are recorded at fair value. See Note 8 for further information on derivative liabilities.
	The Company's assets and liabilities carried at fair value are categorized using inputs from the three levels of fair value hierarchy, as follows:
		Level 1:	Quoted prices in active markets for identical assets or liabilities.
		Level 2:	Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
		Level 3:	Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the liabilities.
Earnings Per Share, Policy [Policy Text Block]	'
	Earnings (loss) per share
	Basic earnings (loss) per share (“EPS”) is computed by dividing the net income (loss) attributable to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator) during the reporting periods. Fully diluted earnings per share is computed by increasing the denominator by the weighted average number of additional shares that could have been outstanding from securities convertible into common stock, such as stock options and warrants (using the “treasury stock” method), and convertible preferred stock and debt (using the “if-converted” method), unless the effect on net income per share is antidilutive. Under the “if-converted” method, convertible instruments are assumed to have been converted as of the beginning of the period or when issued, if later. The computations of diluted net loss per share do not include 0 and 392,326 options and warrants which were outstanding as of the years ended December 31, 2013 and 2012, respectively, as the inclusion of these securities would have been anti-dilutive.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	'
	Concentration of Credit Risk
	Financial instruments which potentially expose the Company to concentrations of credit risk include cash equivalents, trade accounts receivable, accounts payable and accrued liabilities. The Company restricts its cash equivalents to money market accounts with major banks and U.S. government and corporate securities which are subject to minimal credit and market risk.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recent accounting pronouncements
	In July 2013, the FASB issued ASU 2013-11, Presentation of Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists, an amendment to FASB Accounting Standards Codification (“ASC”) Topic 740, Income Taxes (“FASB ASC Topic 740”). This update clarifies that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. In situations where a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction or the tax law of the jurisdiction does not require, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013. The adoption of this ASU is not expected to have a material impact on the Company’s financial statements.
	There were no other accounting standards recently issued that had or are expected to have a material impact on the Company’s consolidated financial statements and associated disclosures.

Organization_and_summary_of_si2

Organization and summary of significant accounting policies (Tables)	12 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	'
	The following is a summary of the Company’s allowance for doubtful accounts activity for the year ended December 31, 2013: (in thousands)
	Allowance for doubtful accounts, beginning of year	$	—
	Bad debt expense		5
	Write-offs		-5
	Allowance for doubtful accounts, end of year	$	—
Schedule of Inventory, Current [Table Text Block]	'
	Inventories are stated at the lower of cost or net realizable value using the first-in, first-out method and are comprised of the following as of December 31, 2013 and 2012: (in thousands)
		2013			2012
	Raw materials	$	192		$	187
	Work in process		46			—
			238		$	187
	Less: Reserve for excess and obsolete inventory		-134			-134
		$	104		$	53
Property, Plant and Equipment [Table Text Block]	'
	Property and equipment are comprised of the following as of December 31, 2013 and 2012: (in thousands)
		Estimated Useful Lives		2013			2012
	Computers and software	3-5 years		$	254		$	198
	Furniture and fixtures	7 years			50			50
	Demonstration equipment	7 years			464			604
	Leasehold improvements	life of lease			168			110
	Production and laboratory equipment	7 years			126			126
					1,062		$	1,088
	Less: Accumulated depreciation				-469			-420
				$	593		$	668

Joint_Ventures_Tables

Joint Ventures (Tables)	12 Months Ended
	Dec. 31, 2013
Joint Venture [Abstract]	'
Schedule of Assets and Liabilities, Results of Operations of Joint Venture [Table Text Block]	'
	The following is a summary of the assets, liabilities and results of operations for UPA for the year ended December 31, 2013 and 2012 (in thousands):
		2013		2012
	Current assets	$	87	$	77
	Non-current assets		4		7
	Current liabilities		1,111		305
	Non-current liabilities		0		0
	Revenue		901		0
	Operating expenses		1,687		222
	Net loss		799		223

Short_term_borrowings_Tables

Short term borrowings (Tables)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Schedule of Short-term Debt [Table Text Block]	'
	Short term borrowings consisted of the following at December 31, 2013 and 2012 (in thousands):
		2013		2012
	Project Financing Line of Credit	$	—	$	491
	November 2012 Bridge Notes, 8%, due April 15, 2013		—		3,700
	August 2013 Bridge Notes, 12%, due February 1, 2014		4,000		—
		$	4,000	$	4,191

Convertible_debt_Tables

Convertible debt (Tables)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Schedule of Debt Conversions [Table Text Block]	'
	Convertible debt consisted of the following at December 31, 2013 and 2012 (in thousands):
		2013		2012
	December 2011 Convertible Promissory Notes, 12.5%, due on demand on or after January 31, 2013	$	—	$	1,250
	Roenigk 2012 Convertible Promissory Note, 8%, due March 31, 2014, less discount of $22 at December 31, 2013 and $106 at December 31, 2012		2,083		1,838
			2,083		3,088
	Less: Current portion		-2,083		-1,250
		$	—	$	1,838

Equity_Tables

Equity (Tables)	12 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
Option Expenses [Table Text Block]	'
	The following table presents non-cash stock option expense included in expenses in the Company’s Consolidated Statements of Operations for the years ended December 31, 2013 and 2012 (in thousands):
		2013			2012
	Cost of revenue	$	—		$	4
	General and administrative		223			548
	Engineering, research and development		26			77
	Sales and marketing		6			126
	Option expense before tax		255			755
	Income tax benefit		—			—
	Net option expense	$	255		$	755
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
	The fair value of options granted during 2013 and 2012 were estimated at the date of grant using the Black-Scholes option pricing model with the following assumptions:
		2013		2012
	Risk-free interest rate	0.92% - 1.07%		0.83% - 2.23%
	Expected option life (years)	6.25		6.25 – 10.0
	Expected volatility	90% - 91%		90% - 92%
	Expected dividend rate	0%		0%
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
	A summary of the Company’s stock option activity and related information for the years ended December 31, 2013 and 2012 follows:
		2013					2012
		Number of		Wtd. Avg.			Number of	Wtd. Avg.
		Shares		Price per			Shares	Price per
				Share				Share
	Outstanding, beginning of year	24,896,678		$	0.32		19,674,102	$	0.38
	Granted	14,450,000		$	0.09		7,560,000	$	0.16
	Canceled and expired	-7,838,601		$	0.28		-2,337,424	$	0.29
	Outstanding, end of year	31,508,077		$	0.22		24,896,678	$	0.32
	Vested and exercisable, end of year	17,254,952		$	0.33		14,700,574	$	0.4
Tabular Disclosure Related To Warrants Expiration Date [Table Text Block]	'
	At December 31, 2013, there were outstanding warrants for the purchase of 137,631,302 shares of the Company’s Common Stock at prices ranging from $0.10 per share to $0.55 per share (weighted average exercise price was $0.15 per share). The expiration dates of outstanding warrants as of December 31, 2013 are as follows:
	Expiration	Warrants
		Outstanding
	2014	1,531,103
	2015	296,293
	2016	20,625,815
	2017	44,570,061
	2018	69,265,530
	2019 and later	1,342,500
		137,631,302

Derivative_Liabilities_Tables

Derivative Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Derivative Liability [Abstract]	'
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
	Assets and liabilities measured at fair value on a recurring basis as of December 31, 2013 are as follows: (in thousands)
				Fair Value Measurements at Reporting Date Using
	Description	Balance as of		Quoted Prices		Significant		Significant
		December 31,		in Active		Other		Unobservable
		2013		Markets for		Observable		Inputs
				Identical		Inputs		(Level 3)
				Assets		(Level 2)
				(Level 1)
	Liabilities
	Derivative liability – long-term portion	$	186	$	-	$	-	$	186
	Total	$	186	$	-	$	-	$	186
	Assets and liabilities measured at fair value on a recurring basis as of December 31, 2012 are as follows: (in thousands)
				Fair Value Measurements at Reporting Date Using
	Description	Balance as of		Quoted Prices		Significant		Significant
		December 31,		in Active		Other		Unobservable
		2012		Markets for		Observable		Inputs
				Identical		Inputs		(Level 3)
				Assets		(Level 2)
				(Level 1)
	Liabilities
	Derivative liability – current portion	$	20	$	-	$	-	$	20
	Derivative liability – long-term portion		2,214		-		-		2,214
	Total	$	2,234	$	-	$	-	$	2,234
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'
	The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liabilities classified as Level 3 for the years ended December 31, 2013 and 2012 (in thousands):
		2013		2012
	Balance at beginning of year	$	2,234	$	807
	Recognition of derivative liabilities		607		3,064
	Exercise of derivative instruments		-298		—
	Change in fair value		-2,357		-1,637
		$	186	$	2,234

Income_taxes_Tables

Income taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
	Significant components of the Company's deferred tax assets are as follows as of December 31, 2013 and 2012 (in thousands):
		2013		2012
	Net operating loss carryforwards	$	22,071	$	22,114
	Derivative liabilities		-48		849
	Stock options and warrants		2,227		2,140
	Valuation discount		-9		-40
	Other		251		352
			24,492		25,415
	Valuation allowance – deferred tax assets		-24,492		-25,415
		$	-	$	-
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
	A reconciliation of income tax expense (benefit) at the statutory rate to income tax expense at the Company's effective rate is shown below for the years ended December 31, 2013 and 2012 (in thousands):
		2013		2012
	Computed at statutory rate (34%)	$	-549	$	-2,510
	(Decrease) increase in valuation allowance for deferred tax assets		495		3,130
	Stock and stock options		81		130
	Derivative liabilities		—		-849
	Non-deductible items and other		-27		99
	Benefit for income taxes	$	-	$	-

Commitments_and_contingencies_

Commitments and contingencies (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block]	'
	The following table summarizes the Company’s operating lease commitments on its primary facility at December 31, 2013: (in thousands)
	Payments due in:	Amount
	2014	$	178
	2015		183
	2016		188
	2017		16
		$	565

Organization_and_summary_of_si3

Organization and summary of significant accounting policies (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
Accounts, Notes, Loans and Financing Receivable [Line Items]	'
Allowance for doubtful accounts, beginning of year	$0
Bad debt expense	5
Write-offs	-5
Allowance for doubtful accounts, end of year	$0

Organization_and_summary_of_si4

Organization and summary of significant accounting policies (Details 1) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Inventory [Line Items]	'	'
Raw materials	$192	$187
Work in process	46	0
Inventory, Gross, Total	238	187
Less: Reserve for excess and obsolete inventory	-134	-134
Inventory, Net, Total	$104	$53

Organization_and_summary_of_si5

Organization and summary of significant accounting policies (Details 2) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
In Thousands, unless otherwise specified			Computer Equipment [Member]	Furniture and Fixtures [Member]	Demonstration Equipment [Member]	Leasehold Improvements [Member]	Production and Laboratory Equipment [Member]
Property, Plant and Equipment [Line Items]	'	'	'	'	'	'	'
Computers and software	$254	$198	'	'	'	'	'
Furniture and fixtures	50	50	'	'	'	'	'
Demonstration equipment	464	604	'	'	'	'	'
Leasehold improvements	168	110	'	'	'	'	'
Production and laboratory equipment	126	126	'	'	'	'	'
Property, Plant and Equipment, Gross, Total	1,062	1,088	'	'	'	'	'
Less: Accumulated depreciation	-469	-420	'	'	'	'	'
Property, Plant and Equipment, Net, Total	$593	$668	'	'	'	'	'
Property, Plant and Equipment, Estimated Useful Lives	'	'	'3-5 years	'7 years	'7 years	'life of lease	'7 years

Organization_and_summary_of_si6

Organization and summary of significant accounting policies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Organization and summary of significant accounting policies [Line Items]	'	'
Description of Activities of Parent Company	'developing and marketing advanced municipal and industrial wastewater treatment and carbon reducing power generation technologies.	'
Contract Revenue As Percentage Of Total Revenue	21.00%	'
Property, Plant and Equipment, Depreciation Methods	'straight-line method	'
Gain (Loss) on Disposition of Other Assets	'	$131,000
Long-term Debt, Total	6,083,000	7,279,000
Offsetting Liabilities Noncurrent	100,000	'
Depreciation, Total	189,000	119,000
Advertising Expense	$27,000	$37,000
Employee Stock Option [Member]	'	'
Organization and summary of significant accounting policies [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	'
Warrant [Member]	'	'
Organization and summary of significant accounting policies [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	'	392,326
One Customer [Member]	'	'
Organization and summary of significant accounting policies [Line Items]	'	'
Entity Wide Accounts Receivable Major Customer Percentage	'	53.00%
Concentration Risk, Percentage	'	73.00%
Two Customers [Member]	'	'
Organization and summary of significant accounting policies [Line Items]	'	'
Entity Wide Accounts Receivable Major Customer Percentage	81.00%	'
Three Customers [Member]	'	'
Organization and summary of significant accounting policies [Line Items]	'	'
Concentration Risk, Percentage	76.00%	'
Thermoenergy Power Systems, LLC [Member]	'	'
Organization and summary of significant accounting policies [Line Items]	'	'
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	15.00%	'

Managements_consideration_of_g1

Management's consideration of going concern matters (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Management's consideration of going concern matters [Line Items]	'	'	'
Cash and Cash Equivalents, At Carrying Value	$2,508,000	$4,657,000	$3,056,000
Retained Earnings (Accumulated Deficit), Total	-122,507,000	-120,892,000	'
Proceeds from Short-term Debt, Total	4,223,000	4,191,000	'
Net Income (Loss) Attributable to Parent, Total	-1,615,000	-7,378,000	'
August 2013 Bridge Notes [Member]	'	'	'
Management's consideration of going concern matters [Line Items]	'	'	'
Proceeds from Short-term Debt, Total	$4,000,000	'	'
Line Of Credit Facility, Interest Rate On Default	12.00%	'	'

NYCDEP_Contract_Details_Textua

NYCDEP Contract (Details Textual) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Unusual Risk or Uncertainty [Line Items]	'	'
Gain (Loss) on Contract Termination	$4,878	$0

Joint_Ventures_Details

Joint Ventures (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Schedule of Assets and Liabilities, Results of Operations of Joint Venture [Line Items]	'	'
Current assets	$3,660	$8,265
Current liabilities	8,989	15,459
Non-current liabilities	201	4,085
Revenue	2,812	6,971
Operating expenses	5,360	8,066
Net loss	-1,615	-7,378
Upa [Member]	'	'
Schedule of Assets and Liabilities, Results of Operations of Joint Venture [Line Items]	'	'
Current assets	87	77
Non-current assets	4	7
Current liabilities	1,111	305
Non-current liabilities	0	0
Revenue	901	0
Operating expenses	1,687	222
Net loss	$799	$223

Joint_Ventures_Details_Textual

Joint Ventures (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Joint Ventures [Line Items]	'	'
Other long term liabilities	$15,000	$33,000
Selling and Marketing Expense, Total	1,727,000	2,855,000
Contracts Revenue	2,812,000	6,971,000
Contract Revenue Cost	3,313,000	6,798,000
TEPS [Member]	'	'
Joint Ventures [Line Items]	'	'
Interest In Joint Venture	50.00%	'
Reduction In Value Of Investments In Joint Venture	2,000	26,000
Investments In Joint Venture Carrying Value	'	10,000
BPD [Member]	'	'
Joint Ventures [Line Items]	'	'
Interest In Joint Venture	50.00%	'
UPA [Member]	'	'
Joint Ventures [Line Items]	'	'
Interest In Joint Venture	50.00%	'
Revenue from Grants	901,000	1,000,000
Contracts Received	'	900,000
Other long term liabilities	0	0
Payments to Acquire Interest in Joint Venture	1,250	'
Debt Instrument, Description of Variable Rate Basis	'	'three-month LIBOR rate plus 2% per year
Selling and Marketing Expense, Total	'	129,000
Increase Decrease In Value Of Investment In Joint Venture	296,000	18,000
Contracts Revenue	901,000	0
Debt Instrument, Face Amount	300,000	100,000
UPA [Member] | Subcontract [Member]	'	'
Joint Ventures [Line Items]	'	'
Contracts Revenue	842,000	'
Contract Revenue Cost	896,000	'
Accounts Receivable, Net, Total	293,000	'
Conversion Of Account Receivable To Loan	'	$200,000

Short_term_borrowings_Details

Short term borrowings (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Short-term Debt [Line Items]	'	'
Short term borrowings	$4,000	$4,191
Project Financing Line Of Credit [Member]	'	'
Short-term Debt [Line Items]	'	'
Short term borrowings	0	491
November 2012 Bridge Notes [Member]	'	'
Short-term Debt [Line Items]	'	'
Short term borrowings	0	3,700
August 2013 Bridge Notes [Member]	'	'
Short-term Debt [Line Items]	'	'
Short term borrowings	$4,000	$0

Short_term_borrowings_Details_

Short term borrowings (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Short-term Debt [Line Items]	'	'
Repayment Of Short Term Borrowings And Accrued commitment fees	$785,000	$0
Project Financing Line Of Credit [Member]	'	'
Short-term Debt [Line Items]	'	'
Line of Credit Facility, Maximum Borrowing Capacity	'	700,000
Line Of Credit Facility, Interest Rate on Default	8.00%	'
Line of Credit Facility, Commitment Fee Description	'Upon maturity of the Note, the Company was charged a commitment fee equal to 10% of the aggregate principal amount borrowed under the Credit Facility.	'
Debt Instrument, Face Amount	'	700,000
Repayment Of Short Term Borrowings And Accrued commitment fees	785,000	'
Proceeds from Lines of Credit	'	680,000
Legal Fees	34,000	'
Line of Credit Facility, Amount Outstanding	'	491,000
November 2012 Bridge Notes [Member]	'	'
Short-term Debt [Line Items]	'	'
Line of Credit Facility, Maximum Borrowing Capacity	'	3,700,000
Line of Credit Facility, Interest Rate During Period	'	8.00%
Debt Instrument, Maturity Date	15-Apr-13	'
Debt Conversion, Converted Instrument, Shares Issued	5,005,250	'
Debt Conversion, Converted Instrument, Warrants or Options Issued	50,052,500	'
August 2013 Bridge Notes [Member]	'	'
Short-term Debt [Line Items]	'	'
Line of Credit Facility, Maximum Borrowing Capacity	$4,000,000	'
Line Of Credit Facility, Interest Rate on Default	12.00%	'
Line of Credit Facility, Interest Rate During Period	12.00%	'

Convertible_debt_Details

Convertible debt (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Debt Conversion [Line Items]	'	'
Convertible Debt	$2,083	$3,088
Less: Current portion	-2,083	-1,250
Convertible debt, net	0	1,838
December 2011 Convertible Promissory Notes [Member]	'	'
Debt Conversion [Line Items]	'	'
Convertible Debt	0	1,250
Roenigk 2012 Convertible Promissory Note [Member]	'	'
Debt Conversion [Line Items]	'	'
Convertible Debt	$2,083	$1,838

Convertible_debt_Details_Textu

Convertible debt (Details Textual) (USD $)

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2007

Jun. 30, 2012

Mar. 21, 2007

Dec. 31, 2007

Dec. 31, 2007

Dec. 31, 2013

Dec. 31, 2008

Jun. 30, 2012

Mar. 07, 2008

Dec. 31, 2008

Dec. 31, 2008

Dec. 31, 2008

Dec. 31, 2013

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Roenigk 2007 Convertible Promissory Note [Member]

Roenigk 2007 Convertible Promissory Note [Member]

Roenigk 2007 Convertible Promissory Note [Member]

Roenigk 2007 Convertible Promissory Note [Member]

Roenigk 2007 Convertible Promissory Note [Member]

Roenigk 2007 Convertible Promissory Note [Member]

Roenigk 2008 Convertible Promissory Note [Member]

Roenigk 2008 Convertible Promissory Note [Member]

Roenigk 2008 Convertible Promissory Note [Member]

Roenigk 2008 Convertible Promissory Note [Member]

Roenigk 2008 Convertible Promissory Note [Member]

Roenigk 2008 Convertible Promissory Note [Member]

Roenigk 2008 Convertible Promissory Note [Member]

December 2011 Convertible Promissory Notes [Member]

December 2011 Convertible Promissory Notes [Member]

Roenigk 2012 Convertible Promissory Note [Member]

Roenigk 2012 Convertible Promissory Note [Member]

Roenigk 2012 Convertible Promissory Note [Member]

Roenigk 2012 Convertible Promissory Note [Member]

Roenigk 2012 Convertible Promissory Note [Member]

Convertible Promissory Notes One [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Securities Purchase Agreement [Member]

Minimum [Member]

Maximum [Member]

Debt Conversion [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

5.00%

'

'

'

'

'

'

'

'

'

'

12.50%

'

'

'

5.00%

8.00%

12.50%

Debt Instrument, Unamortized Discount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$22,000

$106,000

'

'

'

'

Debt Instrument, Interest Rate Terms

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'The Note bears interest at the rate of 5% per annum from April 1, 2012 through May 31, 2012, then bears interest at the rate of 8% per annum until the maturity date, March 31, 2014.

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price

'

'

'

$0.50

'

'

'

'

'

$0.50

'

'

'

'

'

'

$0.50

'

'

'

'

Debt Instrument, Frequency of Periodic Payment

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'Interest on the Note is payable semi-annually.

'

'

'

'

'

Debt Instrument Deferral Fees

2,500

'

'

'

'

'

2,500

'

'

'

'

'

'

'

'

5,000

'

'

'

'

'

Additional Accrued Interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

161,000

67,000

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

1,921,303

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Warrants or Options Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

19,213,030

'

'

'

'

'

'

'

Debt Instrument, Annual Principal Payment

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,877,217

'

'

'

Warrant Issued For Purchase Of Common Stock

'

750,000

'

'

'

'

'

750,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Investment Warrants Exercise Price1

'

'

'

'

$0.50

$1

'

'

'

'

$0.50

$1

'

'

'

'

'

'

'

'

'

Debt Instrument, Face Amount

'

'

'

750,000

'

'

'

'

'

750,000

'

'

'

'

'

'

'

'

'

'

'

Amount Of Investment Subject To Option

'

'

'

'

'

'

'

'

'

'

'

'

750,000

'

'

'

'

'

'

'

'

Interest Payable, Current

'

'

213,000

'

'

'

'

'

165,000

'

'

'

'

'

'

'

'

'

'

'

'

Bridge Loan Exchanged For Promissory Note

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,250,000

'

'

'

'

'

'

Interest Expense, Total

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$84,000

$153,000

'

'

'

'

Equity_Details

Equity (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Cost of revenue	$3,313	$6,798
General and administrative	3,179	4,751
Engineering, research and development	454	460
Sales and marketing	1,727	2,855
Net option expense	255	755
Stock Option [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Cost of revenue	0	4
General and administrative	223	548
Engineering, research and development	26	77
Sales and marketing	6	126
Option expense before tax	255	755
Income tax benefit	0	0
Net option expense	$255	$755

Equity_Details_1

Equity (Details 1) (Black Scholes Option Pricing Model [Member])	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Expected option life (years)	'6 years 3 months	'
Expected dividend rate	0.00%	0.00%
Minimum [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Risk-free interest rate	0.92%	0.83%
Expected option life (years)	'	'6 years 3 months
Expected volatility	90.00%	90.00%
Maximum [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Risk-free interest rate	1.07%	2.23%
Expected option life (years)	'	'10 years
Expected volatility	91.00%	92.00%

Equity_Details_2

Equity (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Outstanding, beginning of year (in shares)	24,896,678	19,674,102
Granted (in shares)	14,450,000	7,560,000
Canceled (in shares)	-7,838,601	-2,337,424
Outstanding, end of period (in shares)	31,508,077	24,896,678
Vested and exercisable, end of year (in shares)	17,254,952	14,700,574
Outstanding, beginning of year (in dollars per share)	$0.32	$0.38
Granted (in dollars per share)	$0.09	$0.16
Canceled (in dollars per share)	$0.28	$0.29
Outstanding, end of year (in dollars per share)	$0.22	$0.32
Vested and exercisable, end of year (in dollars per share)	$0.33	$0.40

Equity_Details_3

Equity (Details 3)	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Warrants	137,631,302
Year 2014 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Warrants	1,531,103
Year 2015 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Warrants	296,293
Year 2016 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Warrants	20,625,815
Year 2017 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Warrants	44,570,061
Year 2018 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Warrants	69,265,530
Year 2019 and later [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Warrants	1,342,500

Equity_Details_Textual

Equity (Details Textual) (USD $)

1 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Oct. 31, 2012

Aug. 31, 2012

Jul. 31, 2012

Jan. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Mar. 20, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2007

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Stock Option Plan 1997 [Member]

Stock Option Plan 2008 [Member]

Stock Option Plan 2008 [Member]

Stock Option Plan 2008 Amendment [Member]

Bridge Notes December 2011 and Bridge Notes November 2012 [Member]

Roenigk 2007 Convertible Promissory Note [Member]

Employee and Advisor and Board Of Director [Member]

Employee and Advisor and Board Of Director [Member]

Series A Convertible Preferred Stock [Member]

Series A Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B1 Convertible Preferred Stock [Member]

Series B1 Convertible Preferred Stock [Member]

Series C Convertible Preferred Stock [Member]

Series C Convertible Redeemable Preferred Stock [Member]

Warrant [Member]

Common Stock [Member]

Common Stock [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Investors Group One [Member]

Investors Group Two [Member]

Investors Group Three [Member]

Arc Capital (Bvi) Limited [Member]

Pipe Investors [Member]

Warrant Amendment Agreements [Member]

Warrant Amendment Agreements [Member]

Employee and Advisor and Board Of Director [Member]

Employee and Advisor and Board Of Director [Member]

Employee and Advisor and Board Of Director [Member]

Employee and Advisor and Board Of Director [Member]

Common Stock [Member]

Minimum [Member]

Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number Of Common Stock To Purchase Upon Warrants Acquired

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

137,631,302

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Capital Shares Reserved for Future Issuance

'

'

'

'

426,000,000

'

'

40,000,000

20,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

'

'

'

'

$0.07

$0.11

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value

'

'

'

'

$499,000

$1,137,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'6 years 8 months 12 days

'

'

'7 years 8 months 12 days

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.15

'

'

0.1

'

'

0.55

'

'

0.1

0.1

0.1

'

'

'

'

Expected forfeiture rate

'

'

'

'

5.00%

5.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock, shares authorized

'

'

'

'

800,000,000

425,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, shares authorized

'

'

'

'

50,000,000

30,000,000

'

'

'

'

'

'

'

'

208,334

208,334

1,000,000

12,000,000

11,000,000

11,000,000

15,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

208,334

208,334

551,725

11,664,993

8,919,854

0

13,853,106

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross

'

'

'

'

14,450,000

7,560,000

750,000

'

'

'

'

'

14,450,000

7,560,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Price Per Share, exercisable, end of period

'

'

'

'

$0.33

$0.40

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.05

$0.05

$0.09

$1.50

$0.09

$0.27

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized

'

'

'

'

568,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition

'

'

'

'

'1 year 6 months

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equivalent Price Of Common Stock Price Per Share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.08

'

'

'

'

'

'

'

'

'

'

'

$0.08

'

'

Effective Price Of Convertible Preferred Stock Per Share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.08

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period Shares Others

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6,031,577

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Surrendered During Period

'

'

'

'

39,205,234

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

3,765,000

8,287,500

17,316,250

5,633,344

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,839,500

'

'

'

'

'

29,368,750

'

'

'

'

'

'

'

'

'

419,180

9,274,364

'

'

Debt Conversion, Original Debt, Amount

'

'

'

'

'

'

'

'

'

'

4,950,000

'

'

'

'

'

'

'

'

'

100

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest Payable

'

'

'

'

'

'

'

'

'

'

314,177

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants To Purchase Common Stock

'

'

'

'

69,265,530

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6,926,553

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Preferred Shares Purchase Description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'the number of shares of Series C Convertible Redeemable Preferred Stock that would be purchased for $100 at a purchase price of $0.76 per share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Investment Warrants, Exercise Price

$0.15

$0.15

$0.15

'

$0.11

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.10

$0.30

Convertible Preferred Stock Shares Exchanged

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

41.67

'

'

'

131.58

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Preferred Stock, Shares Issued upon Conversion

'

'

'

'

10

'

'

'

'

'

'

'

'

'

'

'

2,193,414

'

'

'

6,926,553

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Redemption Price Per Share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.76

$0.76

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Liquidation Preference Per Share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1.20

$1.20

$2.40

$2.40

$2.40

$2.40

$1.52

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Issued for Services

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

419,180

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, Issued for Services

'

'

'

'

'

88,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds From Issuance Of Common Stock and Warrants

'

'

'

498,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,565,908

729,068

331,196

'

'

'

'

Number Of Warrant Issued

4,141,500

9,116,250

18,670,375

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrant Issued For Purchase Of Common Stock

'

'

'

'

'

'

'

'

'

'

'

750,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,354,125

828,750

376,500

'

'

'

'

Purchase Price Of Shares And Warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,731,625

828,750

376,500

'

'

'

'

Reduction Of Investment Warrants Exercise Price Percentage

'

'

'

'

'

150.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms

'

'

'

'

'

'

'The Plan, which expired on December 31, 2007, provided that the exercise price of each option must be at least equal to 100% of the fair market value of the Common Stock on the date of grant. The Plan contained automatic grant provisions for non-employee Directors of the Company.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Non Qualified Stock Options Granted To Directors

'

'

'

'

'

'

'

30,000

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Preferred Stock Conversion Per Share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.08

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Temporary Equity, Carrying Amount, Attributable to Parent

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3,509,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative_Liabilities_Details

Derivative Liabilities (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Derivative [Line Items]	'	'
Derivative liabilities - current portion	$0	$20
Derivative liabilities - long-term portion	186	2,214
Total	186	2,234
Fair Value, Inputs, Level 1 [Member]	'	'
Derivative [Line Items]	'	'
Derivative liabilities - current portion	'	0
Derivative liabilities - long-term portion	0	0
Total	0	0
Fair Value, Inputs, Level 2 [Member]	'	'
Derivative [Line Items]	'	'
Derivative liabilities - current portion	'	0
Derivative liabilities - long-term portion	0	0
Total	0	0
Fair Value, Inputs, Level 3 [Member]	'	'
Derivative [Line Items]	'	'
Derivative liabilities - current portion	'	20
Derivative liabilities - long-term portion	186	2,214
Total	$186	$2,234

Derivative_Liabilities_Details1

Derivative Liabilities (Details 1) (Fair Value, Inputs, Level 3 [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Fair Value, Inputs, Level 3 [Member]	'	'
Derivative [Line Items]	'	'
Balance at beginning of period	$2,234	$807
Recognition of derivative liabilities	607	3,064
Exercise of derivative instruments	-298	0
Change in fair value	-2,357	-1,637
Balance at end of period	$186	$2,234

Derivative_Liabilities_Details2

Derivative Liabilities (Details Textual) (USD $)	6 Months Ended	12 Months Ended
	Jun. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Derivative [Line Items]	'	'	'
Fair Value Assumptions, Exercise Price	'	$0.08	'
Share Price	'	$0.03	$0.09
Fair Value Assumptions, Expected Volatility Rate	'	70.00%	'
Gain (Loss) on Derivative Instruments, Net, Pretax, Total	'	$2,357,000	$1,637,000
Derivative Liability, Current	'	0	20,000
Increase Decrease In Fair Value Of Derivative Liabilities	607,000	'	3,064,000
Derivative, Gain (Loss) on Derivative, Net, Total	'	$0	($567,000)
Convertible Preferred Stock, Shares Issued upon Conversion	'	10	'
Redeemable Preferred Stock Price, Per Share	'	$0.76	'
Minimum [Member]	'	'	'
Derivative [Line Items]	'	'	'
Fair Value Assumptions, Exercise Price	'	'	$0.10
Fair Value Assumptions, Expected Volatility Rate	'	'	55.00%
Fair Value Assumptions, Risk Free Interest Rate	'	0.04%	0.16%
Fair Value Assumptions, Expected Term	'	'2 months	'5 months
Maximum [Member]	'	'	'
Derivative [Line Items]	'	'	'
Fair Value Assumptions, Exercise Price	'	'	$0.36
Fair Value Assumptions, Expected Volatility Rate	'	'	75.00%
Fair Value Assumptions, Risk Free Interest Rate	'	1.39%	0.72%
Fair Value Assumptions, Expected Term	'	'51 months	'55 months
Series B Convertible Preferred Stock [Member]	'	'	'
Derivative [Line Items]	'	'	'
Convertible Preferred Stock, Shares Issued upon Conversion	'	2,193,414	'
Common Stock [Member]	'	'	'
Derivative [Line Items]	'	'	'
Exercise Price Description	'	'	'if the Company issues and sells any shares of Common Stock or securities convertible into Common Stock (Convertible Securities) at a price less than $0.10 per share at any time on or before January 11, 2014 (a Dilutive Transaction), the purchase price for the shares shall automatically be reduced to a price equal to the price at which such shares were issued and sold (the Reduced Price), and the Company will issue to the Investors, for no additional consideration, a sufficient number of additional shares so that the effective price per share equals the Reduced Price.
Warrant [Member]	'	'	'
Derivative [Line Items]	'	'	'
Exercise Price Description	'	'	'The Warrants include a similar price protection provision pursuant to which, upon a Dilutive Transaction, the exercise price of the Warrants shall automatically be reduced to a price equal to 150% of the Reduced Price. Upon such adjustment, the number of shares issuable upon exercise shall automatically be adjusted by multiplying the number of shares issuable upon exercise of such warrant immediately prior to the Dilutive Transaction by a fraction, (i) the numerator of which shall be the exercise price immediately prior to the Dilutive Transaction and (ii) the denominator of which shall be the exercise price as adjusted.

Related_party_transactions_Det

Related party transactions (Details Textual) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
In Thousands, unless otherwise specified			Bpd [Member]	Alexander Fassbender [Member]	Unrelated Third Party [Member]	Parent Company [Member]
Related Party Transaction [Line Items]	'	'	'	'	'	'
Stockholders Equity Attributable To Noncontrolling Interest	$0	($2)	'	'	'	'
Noncontrolling Interest, Ownership Percentage by Parent	'	'	'	7.50%	7.50%	85.00%
Interest In Joint Venture	'	'	50.00%	'	'	'

Income_taxes_Details

Income taxes (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Income taxes [Line Items]	'	'
Net operating loss carryforwards	$22,071	$22,114
Derivative liabilities	-48	849
Stock options and warrants	2,227	2,140
Valuation discount	-9	-40
Other	251	352
Deferred Tax Assets, Gross, Total	24,492	25,415
Valuation allowance - deferred tax assets	-24,492	-25,415
Deferred Tax Assets, Net of Valuation Allowance, Total	$0	$0

Income_taxes_Details_1

Income taxes (Details 1) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Income taxes [Line Items]	'	'
Computed at statutory rate (34%)	($549)	($2,510)
(Decrease) increase in valuation allowance for deferred tax assets	495	3,130
Stock and stock options	81	130
Derivative liabilities	0	-849
Non-deductible items and other	-27	99
Benefit for income taxes	$0	$0

Income_taxes_Details_Textual

Income taxes (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income taxes [Line Items]	'	'
Deferred Tax Assets Changes In Valuation Allowance	$24,500,000	$25,400,000
Maximum Amount Of Operating Loss Carryforwards For Income Tax	300,000	'
Interest And Penalties Abated Value	2,263,000	'
Operating Loss Carry forwards Expiration Dates, Description	'expire in various amounts during 2014 through 2033	'
Operating Loss Carryforwards	$62,200,000	'
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%	'

Segments_Details_Textual

Segments (Details Textual) (United States)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
United States	'	'
Segment Reporting Disclosure [Line Items]	'	'
Revenues Percentage	74.00%	91.00%

Commitments_and_contingencies_1

Commitments and contingencies (Details) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]	'
2014	$178
2015	183
2016	188
2017	16
Operating Leases, Future Minimum Payments Due, Total	$565

Commitments_and_contingencies_2

Commitments and contingencies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Commitments and Contingencies [Line Items]	'	'
Amount Of Tax Due Without Interest Or Penalties	'	$2,134,636
Income Taxes Final Payment	'	176,636
Income Tax Examination, Penalties and Interest Accrued, Total	399,000	399,000
Operating Leases, Rent Expense	$173,000	$168,000

Subsequent_Events_Details_Text

Subsequent Events (Details Textual) (Subsequent Event [Member], USD $)	Feb. 28, 2014
Subsequent Event [Member]	'
Subsequent Event [Line Items]	'
Debt Instrument, Face Amount	$5,877,217.12